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ABSTRACT 
 
Integrated Functions of Transforming Growth Factor Beta, Latency Associated Peptide, 
and Integrins During Early Porcine Pregnancy. (December 2009) 
Dana A. Massuto, B.S., University of the Sciences in Philadelphia 
Chair of Advisory Committee: Dr. Laurie A. Jaeger  
 
In pigs and other mammals, embryonic losses often occur during implantation 
when the conceptus (embryo plus its extra-embryonic membranes) attaches to the 
maternal uterine epithelium.  Mechanisms controlling this process are not completely 
understood.  Integrins and growth factors are among many molecules likely involved in 
controlling implantation.  Numerous integrins (ITG), including subunits ITGAV (alpha 
v), ITGB1 (beta 1), ITGB3 (beta 3), and ITGB5 (beta 5), and transforming growth factor 
betas (TGFBs), in both latent and active forms, are present at the porcine conceptus-
maternal interface.  TGFBs are released as latent precursors which cannot interact with 
TGFBRs prior to their activation.  Latency associated peptide (LAP), part of the TGFB 
latent complex, contains an amino acid sequence Arg-Gly-Asp (RGD) that is found in 
other extracellular matrix molecules and may interact with and signal through integrins.  
We hypothesize that LAP will bind to and activate ITGAV-containing heterodimers at 
the conceptus-maternal interface and that these interactions are a functional component 
of implantation.  We also hypothesize that TGFB acting via TGFBRs has critical roles 
iv 
during peri-implantation, and such roles may include promoting conceptus development, 
survival, and adhesion.  
Immunofluorescence was used to colocalize TGFB, LAP, and integrins in 
porcine peri-implantation uterus and conceptus; immunohistochemistry of 
phosphorylated SMAD2/3 provided evidence of TGFB activity.  Affinity 
chromatography identified cell surface integrins on porcine trophectoderm that are 
capable of binding LAP.  In vivo, intrauterine infusions of LAP with its native RGD site 
(LAP-RGD) resulted in inhibition of conceptus elongation; LAP-RGE infusions yielded 
normal-appearing filamentous conceptuses at d13 of pregnancy.  At d24, allantois length 
and fetal weights were greater in gilts which received LAP-RGE infusions compared to 
controls which received vehicle only.    
Results provide evidence for 1) active and latent TGFB in porcine conceptus and 
uterus; 2) receptor-ligand interactions of integrins and LAP; 3) integrin aggregation and 
potential focal adhesion formation at the conceptus-maternal interface; and 4) TGFB- 
and/or integrin-associated mechanisms which regulate conceptus elongation and 
placental and fetal size.  Collectively, results suggest that TGFB and integrins are 
extensively involved in communication at the porcine conceptus-maternal interface, 
particularly regulating conceptus development, adhesion, and placental and fetal 
development. 
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CHAPTER I 
INTRODUCTION 
 
Embryonic loss in domestic swine presents a major reproductive problem 
resulting in fewer total piglets per sow per year.  Discovering ways to improve 
reproductive success is beneficial for improving porcine livestock production, and such 
improvements can be relevant to pregnancy loss in other mammals including humans.  A 
significant proportion of pregnancy loss in pigs occurs during the first 25-30 days of 
gestation (Flint et al. 1982, Jainudeen & Hafez 1987).  During this period, one of the 
critical events influencing pregnancy success is conceptus development and attachment to 
the uterine epithelium (Cross et al. 1994).   
Implantation, a critical period during pregnancy, is initiated when the conceptus 
comes in close proximity to the uterine luminal epithelium (LE), comprising what may be 
referred to as the conceptus-maternal interface.  The implantation process varies among 
species.  Unlike that in mice and humans, which exhibit an invasive type of implantation, 
implantation in pigs is superficial, during which the blastocyst does not invade maternal 
tissues.  Placental types also vary among species and are divided into three main 
categories: hemochorial, epitheliochorial, and endotheliochorial.  Epitheliochorial 
implantation in pigs results in interdigitation of the microvilli of the trophectoderm and 
the uterine LE along with further interdigitation of the chorion and maternal tissue (Keys 
& King 1990).  This interdigitation of conceptus and maternal tissues provides increased     
_________ 
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surface area for contact and communication in this non-invasive type of implantation. 
Cells of the uterus and conceptus must communicate to establish successful implantation.  
Autocrine, paracrine, and juxtacrine communication present at the interface involves a 
variety of molecules necessary for implantation including, but not limited to, cytokines, 
growth factors, ECM proteins, proteases, protease inhibitors, interferons, integrins, and 
steroid hormones (Bazer 1992, Bowen et al. 1996, Lessey & Arnold 1998, Bowen & 
Hunt 2000, Carson et al. 2000, Jaeger et al. 2001, Burghardt et al. 2002, Lessey 2002, 
Dey et al. 2004, Armant 2005, Lea & Sandra 2007, Guzeloglu-Kayisli et al. 2009).  
Synchrony between conceptus and uterine communication is essential for promoting a 
uterine environment that is receptive to the attaching conceptus.  In the absence of 
synchrony, defects in implantation leading to the loss of pregnancy may result (Pope et 
al. 1982, Geisert et al. 2006, Ross et al. 2007).  Mechanisms supporting porcine 
conceptus development and attachment are not well defined, and alterations in autocrine, 
paracrine, and juxtacrine signaling during the peri-implantation period likely contribute 
to reproductive failure.  Therefore, the mechanisms involved in conceptus development 
and attachment are the focus of this project, with a particular emphasis on specific 
integrins and growth factors.  
The beta transforming growth factors (TGFBs) and their type I and type II 
receptors (TGFBR1, TGFBR2) are among the growth factors that have been identified at 
the conceptus-maternal interface (Gupta et al. 1996, Gupta et al. 1998a, Gupta et al. 
1998b).  Active TGFBs are functional when they bind to TGFB receptors; however, 
functional ligand-receptor interactions of TGFBs at the porcine conceptus-maternal 
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interface have not been fully defined.  In addition to TGFBs, numerous integrin 
heterodimers, which have the ability to bind to many extracellular matrix (ECM) 
proteins, have also been identified at this interface (Bowen et al. 1996, Burghardt et al. 
2002, Erikson et al. 2009).  Evidence suggests that TGFBs and integrins may be key 
players during porcine implantation, and further understanding their specific roles, 
interactions, and the signals they transmit during porcine implantation are the major 
focuses of this project. 
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CHAPTER II 
LITERATURE REVIEW 
 
Porcine Blastocyst Development  
Pigs are classified as a polyestrus, spontaneous ovulators with an approximately 
21-day estrus cycle.  At release of the ova, progression of the oocyte within the oviduct is 
slow and continuous, which is similar to that in other litter bearing species.  The uterine 
tube, commonly referred to oviduct, is approximately 25 cm in length and is divided into 
three main segments: the infundibulum, the ampulla, and the isthmus, with 
distinguishable ampulla-isthmic and utero-tubal junctions (Brüssow 1985).  The uterine 
tube supports preparation of the gametes, fertilization, and development of the zygote.  
Within the uterine tube, the fertilized ovum undergoes its first cleavage by 26 h after 
fertilization (Brüssow et al. 2008).  The embryo undergoes further cleavages, and during 
the 8 to 16 cell stage, activation of the porcine conceptus genome must occur as a 
prerequisite for successful pregnancy (Dey et al. 2004).   
The embryo is encased within an anti-adhesive barrier, the zona pellucida (ZP), 
which helps facilitate migration through the oviduct by resisting adhesion to the uterine 
tube wall (Carson et al. 2000).  Pioneering work involving in vitro co-culture of sheep 
embryos with oviductal cells determined that oviductal secretions support early embryo 
development (Gandolfi & Moor 1987).  The porcine oviduct secretes proteins such as 
porcine oviductal secretory proteins (POST) 1-3, which are up-regulated during estrus, 
can bind and remain associated to the ZP, and may help facilitate oocyte maturation and 
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early embryo development (Buhi et al. 1990, Buhi et al. 1993).  Other classes of proteins 
identified in the oviductal environment include protease inhibitors, growth factors, 
cytokines, binding proteins, enzymes, and immunoglobulins (Buhi et al. 1997, Buhi et al. 
2000, Buhi & Alvarez 2003).  Of these, the more abundantly synthesized proteins include 
protease inhibitors such as tissue inhibitor of metalloproteinase 1 (TIMP1) (Buhi et al. 
1997) and plasminogen activator inhibitor 1 (PAI1) (Kouba et al. 2000).        
The developing embryo enters the uterus at the 4 to 8 cell stage, between 48 to 56 
h after fertilization, where it continues to develop into a blastocyst.  Differentiation of 
two different cell populations occurs, comprising a peripheral cuboidal cell layer termed 
the trophectoderm and an inner cell mass (ICM).  The trophectoderm contains dense 
microvilli, functions in selective nutrient uptake, and gives rise to the chorion of the 
placenta.  The ICM will give rise to the embryo proper.  When pig blastocysts reach 0.5 
to 1 mm diameter in size, they shed the zona pellucida, and this typically occurs by day 
6-7 of pregnancy.  The blastocyst continues to develop and differentiate into a conceptus 
(embryo and associated extra-embryonic membranes).    
 
Porcine Gastrulation  
Gastrulation or formation of the three distinct germ layers, ectoderm, mesoderm, 
and endoderm, occurs after the blastocyst hatches from the ZP.  In an estrogen stimulated 
uterine environment, enzymes secreted by the trophectoderm and prostaglandins aid in 
the digestion of the ZP and subsequent hatching of the blastocyst (Bazer et al. 1987).  In 
species such as the pig, in which the conceptus undergoes elongation, the polar 
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trophectoderm (Rauber’s layer) directly overlaying the ICM degenerates, exposing the 
ICM.  The ICM rapidly undergoes proliferation and delamination of cells forming a 
hypoblast, which extends on the inner surface of both the ICM and trophoblast, and an 
epiblast, which is the source of all three germ layers, which are all collectively referred to 
as the embryonic disc.  The first morphological sign of cranial and caudal polarity in the 
embryonic disc occurs by day 9 in the pig, and by day 11, the mesoderm and endoderm 
begin to form from the embryonic disc, and are positioned under the epiblast.  Epiblast 
cells have an autonomous tendency to develop into neural tissue; therefore, for the 
remainder of the epiblast to develop into the ectoderm, an active cascade involving bone 
morphogenetic proteins (BMPs) and receptor regulated SMADs (homologous of mothers 
against decapentaplegic in Drosophila and sma-2, -3, and -4 in C. elegans) proteins are 
required (Blomberg et al. 2008).  
The mesoderm layer extends caudally and laterally in between the trophectoderm 
and endoderm. The portion of mesoderm that lies under the embryonic disk is intra-
embryonic, and the portion underlying the trophectoderm is extra-embryonic.  The intra-
embryonic coelom gives rise to the body cavities, and the extra-embryonic mesoderm 
will give rise to the allantois.  In addition, the extra-embryonic mesoderm will later fuse 
with the primitive endoderm, the ectoderm, and trophectoderm to give rise to the yolk 
sac, amnion, and chorion, respectively.  Further fusion of the chorion and allantoic 
membranes gives rise to the chorio-allantoic placenta (Blomberg le et al. 2006, Vejlsted 
et al. 2006, Blomberg et al. 2008).     
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Conceptus Elongation 
Gastrulation in the pig is concomitant with conceptus elongation.  Spherical day 
10 porcine blastocysts (2-6 mm) undergo a morphological transition to larger spheres (10 
to 15 mm) then to tubular forms (15 mm by 50 mm) and finally to filamentous forms (l 
mm by 100-200 mm) (Geisert et al. 1982b).  During the transition from spherical to 
filamentous forms between days 10 to 12 of pregnancy, extra-embryonic tissues elongate 
at a rate of 30 to 45 mm/h, which is the most exaggerated of all species that undergo 
conceptus elongation (Geisert et al. 1982b, Bennett & Leymaster 1989).  The elongated 
conceptus provides increased surface area for exchange of nutrients between the 
conceptus and uterus, and is essential for successful implantation (Stroband & Van der 
Lende 1990).  Initially, porcine conceptus elongation was hypothesized to occur 
primarily through reorganization and remodeling of the cells of the extra-embryonic 
tissues rather than hyperplasia (Geisert et al. 1982a, Pusateri et al. 1990).  More recently, 
hyperplasia has been recognized as a very active component of porcine elongation as it is 
in other ungulates (Bazer et al. 1987, Blomberg le et al. 2006, Blomberg et al. 2008) 
Bazer et al. 1993).     
 
Uterine Histoarchitecture and Placentation 
Uterine endometrium consists of simple columnar luminal epithelium (LE) and an 
underlying lamina propria consisting of an upper stratum compactum and lower stratum 
spongiosum.  Cells of the lamina propria include stromal cells, immune cells, and 
vasculature.  The LE invaginates downward forming tubular compartments with distinct 
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lumens called endometrial glands, and glandular epithelium (GE) lines these lumens.  
The myometrium of the uterus contains inner circular and outer longitudinal layers of 
smooth muscle cells.            
Porcine implantation is epitheliochorial, characterized by being superficial, non-
invasive, and with a uterine LE that remains intact.  Porcine conceptuses undergo 
transuterine migration, and myometrial contractions induced by estrogen and 
prostaglandins may aid in the spacing of conceptuses (King et al. 1982).  By day 13 of 
porcine pregnancy, conceptuses begin to make initial attachments to the uterine LE (Keys 
& King 1990).  Each filamentous conceptus occupies its own segment of the uterine horn, 
and attachment is initiated at the embryonic disk and progresses toward the trophoblastic 
tips (Dantzer 1985, Keys & King 1990).  Attaching conceptuses do not overlap, and 
trophoblastic tips that are exposed to each other undergo necrosis called necrotic tips.  By 
day 24 of pregnancy, complete interdigitation of the LE and trophectoderm provides 
increased surface area of contact between conceptus and maternal tissues (Keys & King 
1990).  In areas where the trophectoderm overlays openings of endometrial glands at the 
luminal surface, specialized absorptive structures called areolae are formed.  Areolae 
begin to appear by day 17 of pregnancy, and specialize in uptake of histotrophic nutrition 
secreted from endometrial glands.  Histotrophic secretions support the growing embryo; 
following establishment of the placenta, the embryo is also supported by the maternal and 
fetal vasculature network termed hematotrophic support.  By day 24 of pregnancy, a 
network of blood vessels arising from the caudal end of the fetal aorta and feeding into 
the umbilical vein is responsible for hematotrophic support (King et al. 1982).  
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The placenta is a transient organ that consists of both fetal and maternal 
components, functions in metabolic exchange, and serves as an endocrine organ.  
Interdigitation of conceptus and maternal tissues maximizes the surface area for 
metabolic exchange in the pig, and the chorion intimately associates with the uterus by 
interdigitating with the endometrium.  Chorionic villi, created by interdigitating chorion 
and endometrium, are uniform in distribution, which characterizes the diffuse porcine 
placenta.  The allantois is another placental compartment that serves as a storage site for 
nutrients but also produces factors such as growth factors.  The amnion directly 
surrounding the fetus supports a uniformly growing fetus.   
The placenta continues to grow until about day 60 to 70 of porcine pregnancy to 
support the growing fetus.  By day 25 of pregnancy, the average number of live embryos 
is 11.  In addition, average for day 25 fetal crown-rump length is 1.8 cm and for fetal wet 
weight is 0.53 g (Knight et al. 1977).              
         
Pregnancy Recognition   
The conceptus is responsible for secreting the signal for pregnancy, and in the pig, 
estrogens produced by the conceptus are believed to be a signal for maternal recognition 
signal of pregnancy (Geisert et al. 1982b).  Exogenous administration of estrogen, in the 
absence of embryos, will induce a false pregnant state called pseudopregnancy.  Because 
the CL is responsible for producing progesterone during pregnancy, inhibition of corpora 
luteal (CL) demise on the ovary is required to maintain a pregnant or pseudopregnant 
state.  Progesterone is essential for regulation of endometrial functions to support events 
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of embryonic development, implantation, and placentation (Bazer 1992).   Progesterone, 
along with estrogens, are the primary effectors responsible for the uterus becoming 
receptive to the conceptus for implantation.     
In the non-pregnant gilt, pulsatile release of prostaglandin F2α (PGF) from the 
endometrial LE is stimulated by pulsatile release of oxytocin binding to oxytocin 
receptors (Gross et al. 1988, Mirando et al. 1995, Edgerton et al. 1996).  PGF is released 
into the uterine venous system beginning on Day 15 or 16 of the estrous cycle and causes 
regression of the CL (Bazer et al. 1989).    
In the pregnant gilt, conceptuses secrete estrogen as a signal for pregnancy when 
they are at least 5 mm in size (Geisert et al. 1990).  Maintenance of pregnancy requires 
biphasic estradiol secretions occurring on days 11-12 of pregnancy and again between 
days 15 and 20 to 25.  Both surges are required to maintain pregnancy (Bazer 1992, 
Geisert & Yelich 1997).  Administration of biphasic exogenous estradiol on day 11 
through 15 of the estrus cycle can maintain the CL for the duration of a normal pregnancy 
of 114 days (Geisert & Yelich 1997).  Inducing asynchrony in the uterine environment 
during this time results in conceptus demise.  This is evident by administration of 
estradiol before day 11 of pregnancy, which results in embryonic loss (Geisert et al. 
2006, Ross et al. 2007).   
The initial hypothesis that steroid hormones are involved in inhibiting regression 
of the CL resulted from the finding that cultured porcine blastocysts synthesize estrogens 
and the detection of estrogens in the pregnant pig by day 16 of pregnancy (Perry et al. 
1973, Robertson & King 1974, Perry et al. 1976).  The endocrine-exocrine theory 
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illustrates how conceptus secretion of estrogen prevents the actions of PGF’s on the CL 
since PGF is secreted in both pregnant and cyclic pigs.  In the cyclic gilt, PGF is secreted 
in an endocrine manner and released towards the utero-ovarian vein where it can reach 
the ovary and lyse the CL.  In the pregnant pig, PGF is secreted in an exocrine manner 
towards the uterine lumen where it cannot reach the utero-ovarian vasculature (Bazer & 
Thatcher 1977).  Estrogen is hypothesized to induce the endocrine-exocrine switch during 
pregnancy or pseudopregnancy by indirectly inducing calcium cycling across the 
epithelia to facilitate exocrine secretion of PGF into the uterine lumen (Bazer 1992).  In 
addition, estrogen increases the ratio of prostaglandin E2 (PGE) to PGF.  PGE aids in 
protecting the CL from luteolytic effects of PGF.  Finally, estrogen also maintains LH 
(luteinizing hormone) receptors in both CL and uterus, which is necessary for steroid 
hormone production (Spencer et al. 2004). 
 
Factors Mediating Conceptus Elongation 
Prior to their attachment to the uterine LE, porcine conceptuses elongate from 
spherical to filamentous forms.  Conceptus loss during this time can approach 20% in 
pigs (Bennett & Leymaster 1989, Blomberg et al. 2008).  Investigating which factors 
mediate conceptus elongation is difficult, in part due to the failure of conceptuses to 
elongate in vitro (Stroband & Van der Lende 1990).  Therefore, the signals responsible 
for initiating conceptus elongation are largely unknown. 
Initially, porcine conceptus elongation was hypothesized to occur primarily 
through reorganization and remodeling of the cells of the extra-embryonic tissues rather 
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than hyperplasia (Geisert et al. 1982a, Pusateri et al. 1990).  However, it was recently 
reported that hyperplasia may be a very active component of porcine elongation as it 
appears to be in other ungulates (Bazer et al. 1987, Blomberg le et al. 2006, Blomberg et 
al. 2008).  The expression of Ki67 in both the embryonic disc and extraembryonic tissues 
provides evidence of proliferation within these anatomical regions.  Ki67 is a protein 
ubiquitously expressed during the G1, S, and G2 phases of the cell cycle and not during 
the G0 phase, which indicates that cell division is active within the trophectoderm and 
embryonic disc during the time conceptuses elongate between day 11 and day 12 of 
pregnancy (Blomberg le et al. 2006).   
Studies involving techniques such as gene analysis were utilized to identify 
abundantly and differentially expressed proteins during the time of conceptus elongation.  
Expression of genes that encode proteins known to be involved in cellular differentiation, 
immune modulation, maternal recognition, protein synthesis, protein trafficking, RNA 
post-transcriptional modification, molecular transport, cell growth /proliferation, cellular 
assembly organization, and cellular morphology have been identified during conceptus 
elongation.  In the tubular stage of conceptus elongation, more than 200 genes associated 
with cell growth /proliferation were identified further supporting that hyperplasia occurs 
during elongation (Blomberg et al. 2008). 
Genes involved in intracellular signaling pathways were also identified during 
conceptus elongation.  Pathways involving integrin, TGFB, and WNT were well 
represented, suggesting mechanisms for maternal growth factor signaling and 
cytoskeletal rearrangement/cell motility during conceptus elongation.  Other genes 
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identified during conceptus elongation included steroidogenic acute regulatory protein 
(StAR), TGFB, epidermal growth factor receptor (EGFR), interferon-gamma, retinol 
binding protein, interleukin 1-beta (IL1B), 17-beta hydroxysteroid dehydrogenase, 
estradiol (E2), cytokeratin 8 and 18, stratifin, ribosomal proteins, and less abundant trans 
retinoic acid, all which may have roles in supporting conceptus elongation (Blomberg et 
al. 2008).  IL1B may be responsible for maternal immune suppression to prevent 
conceptus rejection and modulate estradiol (E2) synthesis via upregulation of aromatase, 
while 17-beta hydroxysteroid dehydrogenase is an important enzyme needed for steroid 
hormone synthesis.  Cytokeratin 8 and 18 may be important for embryonic 
differentiation, and stratifin may be important for cell survival, growth, and migration.  
Finally, ribosomal proteins may be important for protein processing during conceptus 
elongation (Blomberg le et al. 2006, Blomberg et al. 2008).  From these studies, it was 
hypothesized that E2 has a central role in initiating the transition between ovoid to 
tubular stage.   
   
Tolerance of Pregnancy and Other Immunoendocrine Functions 
A large number of spontaneous conceptus loss is thought to occur because of 
dysregulation of the immune system (Wessels et al. 2007).  The conceptus is considered 
semi-allograft because it contains paternally inherited antigens that may be presented on 
apical surfaces by MHC class I (MHC1) glycoproteins.  MHC1 are receptors that are on 
the surface of all nucleated cells and present self or non-self antigens to immune cells 
such as B and T cells.  Successful implantation and pregnancy relies on the ability of the 
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conceptus to circumvent the maternal immune system, and both mother and fetus 
contribute to an immunotolerant uterine environment.  The trophoblast and uterine 
endometrial cells may play an important role in suppressing the immune system by 
producing immunosuppressive and immunotolerant factors such as PGs and TGFB.  In 
addition, progesterone, secreted by the CL in the pig, is immunosuppressive (Hunt 2006).  
Other events critical for conceptus tolerance include down regulation of MHC1 on the 
surface of porcine trophoblast cells (Joyce et al. 2008) and shifting from a T helper 1 
(Th1) to a T helper 2 (Th2) immune state (Croy 2001).    
Cells of the immune system may have other functions in addition to immune 
regulation, which include, but are not limited to, angiogenesis and oxygen sensing.  
Recruitment of immune cells occurs during implantation, and porcine conceptuses recruit 
uterine natural killer lymphocytes (uNK) between days 15 and 28 of pregnancy.  uNK 
cells aggregate around uterine glands and blood vessels, and may aid in angiogenesis via 
up regulating vascular endothelia growth factor (VEGF) and placental growth factor 
(PlGF) (Wessels et al. 2007).  The conceptus also secretes many cytokines such as 
interferons and interleukins that participate in many biological functions during 
implantation.         
            
Window of Implantation 
Apposition and adhesion are two events that comprise porcine implantation (King 
et al. 1982).  Initiation and completion of these phases are dependent upon many factors 
supporting the blastocyst’s ability to achieve morphological transformation and adhere to 
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the uterine endometrium (Albertini et al. 1987, Mattson et al. 1990).  The conceptus-
maternal interface, created at the beginning of apposition, is a focal point for 
communication between the conceptus and uterus.  Bi-directional communication present 
at the conceptus-maternal interface appears to be crucial for establishing and maintaining 
pregnancy.  The autocrine, paracrine, and juxtacrine interactions at the conceptus-
maternal interface are complex and involve many adhesion molecules and other factors.   
Steroid hormones estrogen and progesterone mediate events critical for creating a 
receptive environment for successful conceptus attachment.  Some marked events include 
down regulation of progesterone receptors in the LE and GE, down regulation of anti-
adhesive mucin-1 (MUC1), and an increase in adhesive molecules (Burghardt et al. 1997, 
Burghardt et al. 2002).  Progesterone receptors (PR) are down regulated in the LE and 
GE after day 5 of pregnancy; however, PRs are still evident in the underlying stroma and 
myometrium (Bazer et al. 2009).  The stroma maintains hormonal responsiveness and 
secretory function of the uterine epithelium, and progesterone acting via progesterone 
receptors in the stroma may regulate the decrease of MUC1 on epithelial surfaces and 
increase adhesive molecules such as integrin subunits (ITG) alpha 4 (ITGA4), alpha 5 
(ITGA5), and beta 1 (ITGB1) as a prerequisite for implantation (Burghardt et al. 1997, 
Lessey 2002, Armant 2005).  In addition, progesterone also regulates growth factors such 
as VEGF, fibroblastic growth factor 2 (FGF-2), and FGF receptors 1 and 2 (FGFR1 and 
2) (Jaeger et al. 2001).   
Estrogen, in addition to serving as the porcine maternal recognition signal, 
modulates uterine gene expression that supports uterine histotroph.  Estrogen receptor 
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(ER) alpha is present in LE, trophectoderm, and stroma during the peri-implantation 
period, and ER beta is located in day 12 conceptuses.  Estrogen acting via ERs function 
to increases expression of many factors such as retinol binding protein, 
spermidine/spermine N1-acetyltransferase, ITGB5, F-actin, and osteopontin (SPP1) 
(Spencer et al. 2004).   
 
The Porcine Conceptus-Maternal Interface 
Prostaglandins, interferons, growth factors, integrins, and ECM proteins are some 
of the many factors that are found on the apical surfaces or within histotroph at the 
conceptus-maternal interface.      
   Prostaglandins are among the abundantly detected proteins identified during 
porcine pregnancy, and secretion of prostaglandins is necessary for successful porcine 
pregnancy.  Both conceptuses and endometrium secrete PGE2, and PGF is also present in 
the uterine lumen (Geisert et al. 1982b).  The ratio of PGE2:PGF may have a role in 
regulating the uterine environment.  For example, a higher ratio for PGE2 may aid in 
stabilizing the ECM in addition to regulating immune functions.   
Type I interferons (IFN) such as IFN delta (IFND), and type II IFNs, such as IFN 
gamma (IFNG), are secreted between day 12 and 20 of porcine pregnancy.  In contrast to 
sheep, in which a type I IFN (interferon tau) is the signal for maternal recognition of 
pregnancy, IFNs produced by pig conceptuses do not appear to be antiluteolytic (Spencer 
et al. 2004).  IFN receptors are detected on the uterine LE (Lefevre et al. 1998), and IFNs 
secreted by conceptuses may act via IFN receptors found on the uterine LE, which is an 
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example of the many kinds of paracrine communication detected at the conceptus-
maternal interface.  IFNs may function during porcine pregnancy by increasing secretion 
of prostaglandins, (Harney & Bazer 1989), modulating uterine stromal and GE gene 
expression, and stimulating loss of polarity of the uterine LE for implantation (Joyce et 
al. 2007a, Joyce et al. 2007b, Joyce et al. 2008).  Finally, IFNG also induces MHCII, 
which is detected in the stroma in vascular elements from day 15 on of porcine 
pregnancy. 
Adhesion molecules present during porcine implantation include, but are not 
limited to, integrins (Bowen et al. 1997, Burghardt et al. 2002), secreted phosphoprotein 
(SPP1) (Garlow et al. 2002), fibronectin (FN) (Tuo & Bazer 1996), oncofetal FN (oFN), 
and vitronectin (VN), and heparin sulfate proteoglycans.  SPP1 is uterine derived and 
present in the LE and trophectoderm during implantation.  Unlike in the sheep, porcine 
SPP1 is not detected in the GE until day 35 of pregnancy (Garlow et al. 2002).  SPP1 is 
induced by estrogens secreted by conceptuses and can bind to integrin receptors which 
may promote adhesion of the conceptus to the uterine LE during porcine implantation 
(Erikson et al. 2009).  Fibronectin (FN) is a ubiquitous homodimeric ECM protein that 
has at least 20 different isoforms as a result of alternative splicing.  FN plays a role in 
cellular adhesion, migration, implantation, embryogenesis and oncogenic transformation 
(Rashev et al. 2005).  Abundant FN was detected during porcine pregnancy on the apical 
surfaces of the uterine LE and trophectoderm (Rashev et al. 2005).  Oncofetal FN, a 
variant of FN, has also been detected in trophectoderm and uterine LE throughout porcine 
pregnancy (Tuo & Bazer 1996).  In addition, vitronectin (VN), was detected on the apical 
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surfaces of trophectoderm and uterine LE during the porcine implantation period (Bowen 
et al. 1996).  
Integrins, another class of adhesion molecules, are heterodimeric transmembrane 
glycoprotein receptors and consist of 18 alpha and 8 beta subunits.  24 different 
combinations of alpha and beta subunits forming integrin heterodimers function as 
receptors for specific ECM proteins (Hynes 1992, Yamada & Miyamoto 1995, Giancotti 
1997, Aplin et al. 1998).  Many integrin heterodimers recognize and interact with an 
arginine-glycine-aspartate (RGD) sequence on its ECM protein ligand.  Such ECM 
proteins that contain an RGD sequence include SPP1, FN, VN, and LAP.  Integrins along 
with several potential integrin ligands have been identified at the porcine conceptus-
maternal interface, and these interactions play a major role in supporting conceptus 
adhesions to the uterine LE.   
Heparin sulfate proteoglycans are adhesion molecules that can complex with 
growth factors to modulate cellular action by storing growth factors in basement 
membranes and the ECM.  Growth factors that bind heparin sulfate include FGF-2, FGF-
7, connective tissue growth factor (CTGF), and VEGF, all of which have been identified 
at the porcine conceptus-maternal interface.  FGFs have autocrine and paracrine effects 
and participate in proliferation, migration, angiogenesis, embryonic development, and 
cellular differentiation.  CTGF stimulates mitosis, migration, adhesion and ECM 
production in fibroblasts.  CTFGs may participate in cell migration along with increasing 
expression of adhesion molecules such as FN.  VEGF is expressed in the uterus and 
conceptus and increasingly progresses from day 44-112 of porcine pregnancy.  VEGF 
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receptor 1 (VEGFRI) is primarily expressed in maternal tissues while VEGFRII is 
primarily expressed in trophoblast.  VEGF correlates with fetal weight and placental 
efficiency, and may have roles in the development of the placental vasculature.  Other 
growth factors found at the porcine conceptus maternal interface include insulin-like 
growth factor (IGF-1), epidermal growth factor (EGF), and of particular interest TGFB 
(Jaeger et al. 2001).      
 
Non- Invasive Porcine Implantation 
Like those of all species, porcine conceptuses are inherently invasive.  In artificial 
or ectopic sites, porcine conceptuses are invasive, and sites of invasion accumulate 
collagen deposition (Samuel & Perry 1972).  The stroma of the uterus modulates invasion 
in both invasive and non-invasive species.  Proteases such as plasminogen and 
plasminogen activator (PA), and plasminogen activator inhibitor (PAI), MMPs and their 
inhibitors, TIMPs, are hypothesized to modulate invasiveness of porcine conceptus.  
Plasmin and MMP9 and MMP2 aid in conceptus invasion by degrading the ECM, while 
PAI and TIMPs inhibit the actions of the proteases.     
Plasminogen, the inactive form of plasmin, was detected in early pregnant porcine 
uterine flushes; PA, which converts plasminogen to plasmin, is produced by porcine 
blastocysts during days 10 to 16 in culture (Mullins et al. 1980, Fazleabas et al. 1983).  
Therefore, plasmin is potentially produced within the uterine lumen of pregnant pigs.  
After day 12 of pregnancy, PA could no longer be detected in porcine uterine flushes 
(Mullins et al. 1980, Fazleabas et al. 1983); however, plasminogen activator inhibitor 
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(PAI) is detected in uterine tissues.  The presence of PAI during porcine implantation 
may be important to protect uterine LE from conceptus invasion by inhibiting the 
conversion of plasminogen to active plasmin.  The conversion of plasminogen to plasmin 
may be inhibited in the majority of the uterine environment to prevent degradation of the 
uterine LE and subsequent conceptus invasion.   
MMPs are also detected at the porcine conceptus-maternal interface.  MMP2 was 
detected, in increasing amounts between days 10 to 14, in uterine flushes of pregnant 
sows (Foxcroft et al. 2000, Kayser et al. 2006).  In addition, MMP2 transcripts were 
detected in blastocysts and uterine tissues from days 11 to 16 (Menino et al. 1997, Kayser 
et al. 2006).  MMP9 transcripts were identified in both embryo and uteri between days 15 
and 16 (Menino et al. 1997); however, in other reports, MMP9 was undetectable 
(Foxcroft et al. 2000).  TIMPs were also identified in porcine uterine flushes (Kayser et 
al. 2006) and localized in the trophectoderm and endometrial stroma (Menino et al. 
1997), however, were not detected in the uterine LE or GE.  TIMP expression in the 
trophectoderm may inhibit degradative actions of MMP9 on the ECM.  
Many factors, including but not limited to those mentioned above, appear to play 
a role in the complex communication network at the porcine conceptus-maternal 
interface.  Communication between the conceptus and uterus is essential for successful 
implantation and pregnancy, and appears to modulate phenomena such as pregnancy 
recognition, tolerance of pregnancy, conceptus attachment, and the control of conceptus 
invasion.  Growth factors, such as TGFB, and adhesion molecules, such as integrins, 
appear to play an intricate role in this communication network at the conceptus-maternal 
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interface.  The project focus is of the roles that TGFBs and integrins play in promoting 
successful conceptus development and attachment.   
 
Transforming Growth Factor Beta 
TGFB belongs to the TGFB superfamily, which includes BMPs, activins, and 
inhibin alpha (Massague 1990).  Mammalian TGFBs consist of three different isoforms 
(TGFB 1, 2, and 3), each of which is encoded on a separate chromosome (Munger et al. 
1997).  Unless otherwise noted, reference to TGFB in this document refers to the TGFB1 
isoform.  TGFB is a disulfide-linked dimer of two identical chains of 112 amino acids.  
Each chain is synthesized as the C-terminal domain of a 390 amino acid precursor.  The 
5’ region of the TGFB gene contains 2 transcriptional start sites, and expression of 
TGFBs can be regulated by a number of factors including estrogen, progesterone, 
glucocorticoids, integrins, and TGFBs themselves (Kim et al. 1990, Kanzaki et al. 1995, 
Arici et al. 1996, Ortega-Velazquez et al. 2003).       
TGFBs are synthesized as homodimeric proproteins, and the pre-propeptide 
latency associated peptide (LAP) is cleaved from the mature TGFB dimer by furin-type 
enzymes.  LAP remains non-covalently associated with TGFB comprising the small 
latency complex (SLC) (Munger et al. 1997, Rifkin et al. 1999).  The SLC is usually 
associated with one of several TGFB binding proteins (latent TGFB binding proteins; 
LTBPs) forming the large latency complex (LLC) (Munger et al. 1997).   
LTBPs belong to the fibrillin-like ECM family and have 4 different isoforms.  
LTBPs range in sizes from 124-210 kDa, and most have two protease sensitive regions.  
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LTBP1 and LTBP3 associate with the SLC of TGFB 1, 2, and 3 and LTBP4 can only 
associate with TGFB1.  LTBPs covalently bind LAP and serve to link the SLC to the 
extracellular matrix by covalently cross-linking extracellular matrix proteins via 
transglutaminase (Oklu & Hesketh 2000).  LTBPs sequester inactive growth factors and 
serve to target TGFBs to the ECMs by binding to extracellular matrix proteins such as 
fibronectin and fibrillin-1.  LTBPs contain an RGD sequence, but there is no current 
evidence that they bind to integrins via this sequence (Hyytiainen et al. 2004).  LTBPs, 
however, do bind integrins α3β1 and α6β1 for cell adhesion in melanoma cells, but this is 
not via the RGD sequence.  Cells secrete latent forms of TGFBs typically as the LLC 
however, some cases such as in lymphocytes the SLC is secreted.  
 LAP is part of the SLC and LLC and enhances proper folding and secretion of 
TGFB.  LAP is a homodimer and formed within the secretory pathway after the removal 
of a signal sequence and cleavage from the mature TGFB peptide sequence at a 
processing site containing basic AA.  LAP contains mannose-6-phosphate and can 
associate with insulin-like growth factor II/mannose-6-phosphate receptors, which may 
be a mechanism to sequester latent TGFB to cell surfaces and aid in TGFB activation.  
LAP 1 and 3 monomers contain an RGD sequence that is recognized by and binds to 
integrin receptors in multiple tissues (Derynck & Rhee 1987, Munger et al. 1998).  LAP 
1 also contains a DLXXL sequence that directly follows the RGD sequence that may be 
responsible for LAP’s higher affinity binding to integrin αvβ6 (Kraft et al. 1999, Munger 
et al. 1999).  
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Transforming Growth Factor Beta Activation via Proteases 
After latent TGFBs are secreted, activation of the latent forms is required before 
TGFBs can bind their receptors (Rifkin et al. 1999).  Post-translationally, TGFBs become 
available mostly through multiple extracellular activation mechanisms that include 
proteases, thrombospondin-1, and integrins (Lawrence 1996, Munger et al. 1999, 
Murphy-Ullrich & Poczatek 2000, Annes et al. 2002, Mu et al. 2002, Annes et al. 2003). 
Other mechanisms of TGFB activation include reactive oxygen species causing side 
group modifications, and changes in pH (pH 4.5 or lower) causing protein denaturation.   
Plasmin, a well defined activator of TGFB, is generated by proteolysis of 
plasminogen via tissue type plasminogen activator (tPA) or urokinase type plasminogen 
activator (uPA).  Localized activation of TGFB via plasmin is facilitated by 
thrombospondin-1 (TSP-1), a cell surface associated protein, which can bind both 
plasminogen and LAP (Murphy-Ullrich & Poczatek 2000).  Proteolysis of LAP can then 
occur at the cell surface, thus liberating active TGFB.  Other potential targets for plasmin 
include a protease sensitive hinge region of the LTBP, which can liberate LTBP from the 
LLC (Annes et al. 2003).  Similar to plasmin, thrombin can activate TGFB via 
proteolytic cleavage of LAP (Jenkins 2008).  
Another class of proteases, matrix metalloproteinases (MMPs), including MMP2 
and MMP9, proteolytically activate TGFB.  In vivo, proteases may not be the primary 
mechanism for TGFB activation, as protease deficient mice are not completely devoid of 
TGFB activation.  For example, plasminogen null mice share no similarities to TGFB 
null mice while MMP9 null mice exhibit only partial reduction in TGFB (Bugge et al. 
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1995, Lee et al. 2001).  These data suggests that proteolytic cleavage of LAP may that 
multiple mechanisms may compensate for TGFB activation. 
 
Transforming Growth Factor Beta Activation via Integrins 
Based on in vivo studies in mice, activation via TSP1 and integrins may play a 
very important role in non-proteolytic activation of TGFB (Jenkins 2008).  Previous 
studies involving integrin null mice resulted in similar phenotypes to TGFB null mice.  
ITGAV, ITGB6, and ITGB8 knockout mice share similar phenotypes with TGFB1 
knockout mice such as lung and skin inflammation (Huang et al. 1996, Bader et al. 1998, 
Zhu et al. 2002).  More recently, transgenic mice containing a mutant RGE sequence in 
LAP were shown to exhibit a similar phenotype to that of TGFB1 null mice, supporting 
that integrins via the RGD recognition site play a significant role in TGFB activation 
(Yang et al. 2007).  LAP, like many ECM proteins such as fibronectin, osteopontin, and 
vitronectin, contains an RGD site and binds to integrin heterodimers (Derynck & Rhee 
1987, Ruoslahti 1996, Munger et al. 1998, Lu et al. 2002, Ludbrook et al. 2003).  The 
RGD sequence in LAP is conserved in pigs, mice, and humans (Derynck & Rhee 1987).  
To date, LAP has been shown to bind to integrins αvβ1, αvβ3,αvβ5, αvβ6, αvβ8, α5β1, 
α8β1, and platelet integrin αIIbβ3, several of which are implicated in TGFB activation 
(Wipff & Hinz 2008).   
TGFB activation via integrins involves mechanisms such as traction forces in the 
presence and absence of proteases (Keski-Oja et al. 2004).  Integrins αvβ3, αvβ5, αvβ6, 
and possibly αvβ1 have been determined to activate latent TGFB by mechanical forces 
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such as cellular contraction and external stretching (Jenkins et al. 2006, Wipff et al. 
2007).  Both of these mechanisms require: a) latent TGFB of the LLC tethered to an 
ECM that resists traction forces exerted on the LLC, b) LAP bound to integrin receptors, 
and c) presence of the actin cytoskeleton to generate force or provide resistance to 
extracellular forces (Wipff et al. 2007, Wipff & Hinz 2008).  LAP associated with the 
LLC binds via the RGD site to integrins that are linked to the actin cytoskeleton.  It is 
hypothesized that extracellular force, such as ECM rigidity, is applied to the LAP-
integrin complex, causing external stretch on the LLC and subsequent conformational 
change in the latent complex (Keski-Oja et al. 2004, Larson et al. 2006).  The 
conformational change in the latent complex liberates TGFB, and TGFB is therefore, 
available to interact with TGFBRs.  
   Intracellular forces such as cellular contraction may also play a role in 
activating TGFB.  Cellular contraction mediated by the cross bridging of α-smooth 
muscle actin (ACTA2) and myosin is involved in balancing mechanical forces placed on 
the ECM.  These contractile forces have previously been shown to activate TGFB in 
myofibroblast cultures (Wipff et al. 2007).  Contraction of the actin filaments associated 
with integrins generates a force on the LAP- integrin complex, causing a conformational 
change in the LLC, and liberating TGFB from its latent complex.   
Integrins can also aid in activating TGFB in the presence of proteases.  TGFB 
activation via integrin αvβ8 utilizes the transmembrane matrix metalloproteinase-1 
(MT1-MMP or MMP14).  MT1-MMP and αvβ8 form a cell surface complex, and it is 
believed that αvβ8 concentrates latent TGFB, which is then activated by MT1-MMP.  
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Mechanism of activation includes αvβ8 binding to the RGD sequence on LAP, and MT1-
MMP cleaving LAP, releasing TGFB (Mu et al. 2002).   
αvβ6 can activate TGFB in the presence of thrombin.  Thrombin creates 
intracellular force by binding to epithelial protease activated receptor 1 (PAR1), and 
initiating downstream effector Rho kinase induced actin polymerization.  Intracellular 
forces generated by thrombin are exerted on the actin filaments tethered by ITGB6, and 
LAP bound to αvβ6 undergoes a subsequent conformational change thereby activating 
TGFB (Jenkins 2008).   
αvβ3 may activate TGFB in the presence of  MMP2 and MMP9.  αvβ3 has 
docking points for MMP2 and MMP9, and it is hypothesized that integrins serve as a 
common docking port for latent TGFB and MMPs.  MMP2 and MMP9 along with LAP 
interact with αvβ3, and MMPs liberate TGFB from LAP by proteolytically cleaving LAP 
(Wipff & Hinz 2008).    
   
Transforming Growth Factor Beta SMAD Signaling 
Active TGFBs signal through two known receptors, TGFB receptor types I and II 
(TGFBRI and TGFBRII), which are transmembrane serine/threonine kinase receptors and 
present on the cell surface as homodimers (Lin et al. 1992, Franzen et al. 1993).  TGFB1 
and 3 bind to TGFBRII initiating recruitment of TGFBRI and subsequent formation of a 
heteromeric complex.  TGFB sequential binding to TGFBRII and TGFBRI causes serine 
and threonine transphosphorylation of TGFBRI by TGFBRII (Wrana et al. 1994, Chen & 
Weinberg 1995).  TGFBRI then phosphorylates serine residues of downstream effector 
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SMAD proteins 2 and 3 (Macias-Silva et al. 1996, Zhang et al. 1996).  Phosphorylation 
dependent conformational changes in SMAD2/3 enable heteromerization with SMAD4, 
and the resultant SMAD complex translocates into the nucleus (Nakao et al. 1997).  
Within the nucleus, the combination of SMADs and cofactors within the transcriptional 
complex regulate transcriptional activity of target genes including but not limited to those 
encoding for ECM proteins (Neubauer et al. 1999, Okamoto et al. 2002, Xie et al. 2003, 
Bakin et al. 2004, Cho et al. 2006, Sinpitaksakul et al. 2008) and integrins (Zambruno et 
al. 1995, Kagami et al. 1996, Lai et al. 2000). 
SMADs are direct substrates of the TGFB family receptor kinases, and in the 
basal state, SMADs exist as homo-oligomers within the cytoplasm.  SMADs consist of an 
MH1 domain, a linker domain, and an MH2 domain.  The MH1 domain contains the 
DNA binding domain and interacts with transcription factors. The MH2 domain interacts 
with receptors and transcriptional factors and is the site for SMAD oligomerization.  
There are 3 classes of SMADs: receptor activated SMADs (R-SMADs), common 
mediator SMADs (Co-SMADs), and inhibitory SMADs (I-SMADs).  R-SMADs include 
SMAD1, 2, 3, 5, and 8.  SMAD 4 is a Co-SMAD, and I-SMADs include SMAD6 and 7.  
Only R-SMADs contain a C-terminal SSXS motif in the MH2 domain that is 
phosphorylated by receptors.   In the basal state, R-SMADs are localized in the 
cytoplasm, and I-SMADs are within the nucleus.  R-SMADs associate with type I 
receptors and upon ligand activation, R-SMADs are serine phosphorylated (Shi & 
Massague 2003, Brown et al. 2007).  Kinetics of TGFB phosphorylating R-SMADs is 
slow (t 0.5 ~ 5 min), and results in dissociation of SMADs from the receptors.  TGFB 
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mostly induces SMAD3 with SMAD4; or SMAD2, SMAD3, and SMAD 4 heterotrimers 
(Shi & Massague 2003, Brown et al. 2007).   
TGFBRs remain active for 3-4 hours after ligand binding and continuous receptor 
activation maintains SMADs complexes in nucleus.  Inhibition of SMAD accumulation 
in the nucleus can occur via phosphorylation of MAP-kinase sites in the linker region.  
Agonists that activate ERK MAP Kinases are EGF and HGF.  In addition, I-SMADs such 
as SMAD7 and SMAD6 can inhibit receptor activated signaling of TGFB.  High 
concentrations of SMAD6 and SMAD7 are responsible for inhibiting TGFB signaling.  I-
SMADs can bind to TGFB receptors, interfering with phosphorylation of R-SMADs to 
prevent intracellular signaling (Shi & Massague 2003, Brown et al. 2007).  In certain 
physiological cases such as shear stress in vascular endothelial cells, I-SMADs can be up-
regulated.  This response may be mediated by its TGFB acting in an autocrine fashion. 
 
Transforming Growth Factor Beta SMAD-Independent Signaling 
TGFB can also signal through non-SMAD pathways and can activate ERK, JNK, 
and p38 MAPK pathways.  The ability of TGFB to activate SMAD and non-SMAD 
factors such as TAK1/MEKK1, Ras, RhoA, and PP2A have biological roles in addition to 
transcription (Rahimi & Leof 2007).  TGFB activation of RhoA and p38MAPK, along 
with SMAD signaling may induce stress-fiber formation and epithelial to mesenchymal 
transdifferentiation, and TGFB signaling through PP2A has roles in cell cycle 
progression inhibiting proliferation (Rahimi & Leof 2007). 
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Transforming Growth Factor Beta in Reproduction   
TGFBs have cell-type specific actions and contribute to normal growth and 
development in many different types of cells.  Their broad range of functions includes 
regulating cell proliferation, stimulating ECM protein production, suppressing ECM 
protein degradation, and altering the expression of integrins.  Furthermore, TGFBs are 
functional during diverse biological processes such as embryogenesis, tissue repair, 
immunosuppression, and in altered states such as oncogenesis and fibrosis.  Specific roles 
for TGFB during porcine implantation have yet to be fully defined, but TGFB has been 
identified in the reproductive tissues in many species.   
In mice, TGFBs are found in the inner cellular mass and trophectoderm in 
preimplantating conceptuses.  Preimplantation embryo development, haematopoiesis, and 
yolk sac vasculogenesis are defective in a percentage of TGFB1 deficient conceptuses 
suggesting roles for TGFB during these events (Ingman & Robertson 2002).  In addition, 
TGFB1-/- mice exhibit defects in embryonic vascular development and a lethal 
autoimmune syndrome driven by activated CD+4 T cells (Shull et al. 1992).  TGFB2-/- 
mice have defects in the skeletal, cardiac, and genitourinary systems (Sanford et al. 
1997).  TGFB3-/- mice have cleft palate and defects in lung development (Kaartinen et al. 
1995, Proetzel et al. 1995).   
In humans, VEGF production in first trimester trophoblast cells is up-regulated by 
TGFB suggesting that TGFB may have a role in promoting vascular development during 
placentation (Ingman & Robertson 2002).  In addition to promoting vascular 
development, TGFBs are implicated in many other events important for pregnancy.  
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TGFB participates in creating an immunotolerant uterine environment by inhibiting T 
helper type 1 responses, regulating NK cell behavior, and down regulating IFN-gamma 
induced activation (Jones et al. 2006).  In early embryo development, TGFB has been 
attributed with roles in gastrulation and organogenesis.  TGFB may also have roles in 
preparing the endometrium for implantation by regulating hormone production, 
facilitating production of ECM proteins, inducing apoptosis of endometrial epithelial 
cells, and regulating conceptus invasion (Jones et al. 2006).    
TGFB is also expressed in the uterine LE and is proposed to enhance conceptus 
attachment by up regulating production of oFN (Ingman & Robertson 2002).  TGFB is 
also proposed to regulate conceptus invasion by down regulating MMPs and plasmin, 
while up regulating TIMPs and plasminogen activator inhibitor (Foxcroft et al. 2000).  
Plasmin and MMPs have been shown to aid in degradation of the ECM during conceptus 
invasion, and down regulation of these components protects the ECM.  Trophoblast 
invasion can be inhibited in vitro with treatment of exogenous TGFB, and studies 
involving human explant placental cell cultures displayed increased extravillous 
trophoblast cell invasion in the presence of neutralizing TGFB antibodies, while addition 
of exogenous TGFB decreased the invasive capacity (Graham & Lala 1991, Karmakar & 
Das 2002). 
 
Integrin Heterodimers 
 Integrins are cation dependent membrane bound heterodimers that can mediate 
signal transduction through inside-out and outside-in signaling.  Affinity for integrin 
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ligands is dependent on their structure and inside-out signaling can regulate the 
conformation of integrin extracellular domains.  Cytoskeletal adaptor proteins such as 
talin play a role in regulating ligand affinity.  Binding of talin to the beta cytoplasmic tail 
of the integrin heterodimer causes a conformational change in the extracellular regions of 
the alpha and beta subunits and subsequently increases the affinity for ligands (Wegener 
& Campbell 2008).  Integrins can also be activated intracellularly by signals from other 
membrane receptors such as G-protein-coupled receptors that lead to phosphorylation of 
the beta subunit (Takada et al. 2007).   
Outside-in signaling occurs when extracellular ligands bind integrins, which 
induces a conformational change causing separation of the alpha and beta transmembrane 
domains leading to interactions of the cytoplasmic tails with intracellular signaling 
molecules (Takada et al. 2007).  Receptor-ligand interactions between integrins and ECM 
proteins can activate signaling pathways, which ultimately result in changes in 
cytoskeletal organization, gene expression, proliferation, differentiation, and apoptosis 
(Giancotti & Ruoslahti 1999).  In addition, the contacts made between integrins and the 
ECM is important in cell adhesion, migration, and invasion (Gilcrease 2007).  Each 
heterodimer can serve as a receptor for more than one type of ECM protein and different 
heterodimers can function as receptors for the same ECM proteins.  For example, 
fibronectin is a ligand for the integrin heterodimers α4β1, α5β1, α8β1, αvβ1, αvβ3, αvβ5, 
αvβ6, and αvβ8, while vitronectin is a ligand for αvβ3 and αvβ5 (Takada et al. 2007).  
Specificity and redundancy may be crucial for cellular processes such as cell adhesion 
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and migration, and binding of different ligands to the same type of integrin heterodimer 
can transmit different cellular signals depending on the cell type and context.  
  Integrins provide links to the extracellular and intracellular environments.  Upon 
binding of ECM proteins, integrins aggregate to enhance signal transduction and form 
cytoplasmic focal adhesions (Wozniak et al. 2004).  There are 4 different classifications 
of focal adhesions that are based on subcellular localization, size, and composition; these 
include focal complexes, focal adhesions, fibrillar adhesions, and 3-D matrix adhesions 
(Berrier & Yamada 2007).  Focal complexes are small focal adhesions that are located at 
the periphery of migrating cells.  Focal complexes typically precede focal adhesions, 
which are associated with stress fibers in cells on 2-D rigid matrices.  Fibrillar adhesions 
are elongated focal adhesions that contain α5β1, fibronectin, and tensin.  Finally, 3-D 
matrix adhesions occur when fibroblasts adhere to 3-D collagen gels.  
Formation of focal adhesions stabilizes cell attachments to the ECM by 
connecting ECM proteins to the actin cytoskeleton via actin filaments that can further 
assemble into contractile stress fibers (Bershadsky et al. 2006a).  Cells subjected to a 
rigid matrix will reinforce their integrin-matrix adhesions by creating intracellular forces 
matching that of the force within the matrix, resulting in an isometric state.  Initially, 
focal complexes are assembled that associate with the actin filaments (Galbraith et al. 
2007).  Focal complexes further develop into focal adhesions associated with contractile 
stress fibers (Bershadsky et al. 2006a, Bershadsky et al. 2006b).     
In addition to stabilizing cell attachments, integrins also transform mechanical 
forces such as matrix rigidity and cellular contraction into intracellular signals that 
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activate many signaling pathways.  Focal adhesions serve as signaling centers from 
which numerous intracellular pathways can regulate cellular behavior such as growth, 
migration, proliferation, gene expression, tissue repair, and invasion (Larson et al. 2006).  
Focal adhesions formed in cells culture in vitro cell cultures respond to intracellular 
forces generated by actin-myosin interaction or applied externally to the cell through the 
extracellular matrix by altering the size of focal adhesion and their composition 
(Galbraith et al. 2002).  In addition, studies with stem cells demonstrate that matrix 
rigidity sensed via integrins directs stem cell lineage (Engler et al. 2006). 
At least 156 components, including classes of receptor kinases, cytoskeletal 
proteins, and signaling molecules that involve up to 690 interactions, have been identified 
at integrin adhesion sites characterized by focal adhesions (Zaidel-Bar et al. 2007).  The 
integrin adhesome consists of receptor kinases such as focal adhesion kinase (FAK), Src, 
integrin-linked kinase (ILK), and protein kinase B (PKB); cytoskeletal/linker molecules 
such as talin, vinculin, alpha actinin, and filamin; and signaling molecules such as Rho, 
Rac, and Ras.  Assembly of these components at a focal adhesion may depend upon 
mechanical forces applied to integrin-ECM connections. 
  FAK, a tyrosine kinase, localizes at focal adhesions directly to the beta 
cytoplasmic integrin tail or through other components of the focal adhesion such as talin 
and paxillin.  FAK is autophosphorylated at the tyrosine 397 site.  Phosphorylation of 
FAK initiates a cascade of phosphorylation events and promotes interactions with Src-
family kinases, which further phosphorylate FAK and other focal adhesion components 
including paxillin, tensin, and p130Cas.  There are at least 6 tyrosines and a serine that 
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can be phosphorylated on FAK resulting in numerous intracellular cascades regulating 
cellular behaviors including cell adhesion, cell protrusion and migration, cytoskeletal 
reorganization, gene regulation (Hanks & Polte 1997).  
 
Integrin and Growth Factor Receptor Cross-Talk 
Integrins are capable of receptor cross talk with growth factor receptors. 
Cytoplasmic links between integrins and growth factor receptors such as EGFR, PDGFR, 
and TGFBR are made via ILK.  ILK binds directly to the ITGB1 and ITGB3 cytoplasmic 
tails, and ILK assembles with PINCH-1 and NCK2, bridging a link with growth factor 
receptors and integrins while providing a link to the cytoskeleton (Hehlgans et al. 2007).  
Links between integrins and growth factor receptors optimizes activation of growth factor 
receptors.  For example, many growth factor receptors are optimally activated by their 
ligands only under appropriate cell attachments mediated by integrins (Giancotti & 
Ruoslahti 1999).  Integrin aggregation with growth factor receptors has been 
demonstrated by immunoprecipitating αvβ3 complexed with PDGFR, VEGFR, and, of 
particular interest, TGFBRII (Scaffidi et al. 2004, Galliher & Schiemann 2006).   
TGFB and integrin cross-talk has been identified during many biological 
processes, including fibroblast differentiation into myofibroblasts during wound healing. 
During wound healing, myofibroblasts are key players in the reconstructing of connective 
tissue, and fibroblast differentiation into myofibroblasts is largely controlled by 
mechanical and chemical environments (Hinz 2007).   Changes in composition of the 
ECM causes increased stress within the tissue.  Integrins are one of the multiple ways that 
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a cell can sense increasing stress, and this is mediated via their connections to the outside 
environment and actin cytoskeleton via focal adhesions.  Increased ECM and 
incorporation of α-smooth muscle actin (ACTA2) into focal adhesion-linked stress fibers 
augments the contractile activity of fibroblast cells.  TGFB aids in promoting 
myofibroblast development by inducing expression of ECM proteins and ACTA2.  TGFB 
also activates proteins involved in focal adhesion such as FAK and protein kinase B via 
SMAD 3 and p38MAPK, respectively (Horowitz et al. 2007).  Further, TGFB may 
stimulate focal adhesion assembly and size by activation of intracellular Rho and Rho 
kinase that increase myosin contraction thereby increasing endogenous force and size of 
focal adhesions (Wozniak et al. 2004).    
Integrins and growth factor receptor cross-talk may regulate other biological 
events such as cell growth and proliferation via the Ras and ERK intracellular signals and 
activation of transcriptional factors such as SRF and cMyc (Gilcrease 2007).  In addition, 
TGFB induces expression of ITGB3 and ITGB5 in adhered cell cultures via SMAD 
independent pathways involving c-Src kinase and MAPK phosphorylation and SMAD 
dependent pathways, respectively (Pechkovsky et al. 2008).    
        
Transforming Growth Factor Beta and Integrins during Porcine Implantation 
Relevant to our study, TGFBs and their receptors are present at the conceptus-
maternal interface in many species including mice, pigs, and humans.  Expression of 
TGFBs and TGFBRs on days 10, 11, 12, 13, and 14 of pregnancy in the porcine peri-
implantation conceptus and endometrium were previously reported (Gupta et al. 1996, 
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Gupta et al. 1998a, Gupta et al. 1998b).  Uterine flushes on days 10 and 11 contained 
mostly latent forms of TGFBs, while days 12 to 14 contained primarily active TGFBs.  
The conversion of latent TGFB to its active form appears to occur around days 12 to 14 
of porcine pregnancy, which is concomitant with conceptus elongation and the beginning 
to attachment, suggesting that TGFBs may play a role in these processes.  Once activated, 
TGFBs are able to bind to their receptors found on the cell surfaces of both 
trophectoderm and uterine LE.  TGFBRs on apical surfaces of conceptus and uterine 
tissues may bind active TGFBs and increase expression of integrins and several ECM 
proteins including matrix molecules fibronectin, oncofetal fibronectin, and osteopontin.  
Studies that used a porcine trophectoderm cell line (pTr2) provided evidence that TGFBs 
increase expression of FN; LAP and antibodies directed toward TGFB were able to 
inhibit increases in FN, further supporting hypothesized roles of TGFB during porcine 
implantation (Jaeger et al. 2005).   
While integrins appear to be important in mammalian implantation, some of their 
specific functions during implantation are unclear.  Several integrin heterodimers such as 
αvβ1, αvβ3, and αvβ5 have been implicated in mediating implantation in multiple 
species.  In mice, inhibition of αvβ3 via intrauterine injection of neutralizing monoclonal 
antibodies towards αvβ3 resulted in the reduction of implantation (Illera et al. 2000, Illera 
et al. 2003).  Further, deletion of ITGA4, ITGA5, ITGAV, and ITGB1 in mice caused 
failure of chorioallantois fusion, placental defects, and embryonic deaths, respectively 
(Fassler & Meyer 1995, Bader et al. 1998, Chen & Sheppard 2007).  
In pigs, ITA4, ITGA5, ITGAV, ITGB1, ITGB3, and ITGB5 have been identified 
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at the conceptus-maternal interface (Bowen et al. 1996, Burghardt et al. 2002).  
Expression of ITGAV and ITGB1 subunits on the trophectoderm have been confirmed 
via immunoprecipitation of biotinylated pTr2 cells (Jaeger et al. 2005).  Moreover, 
preliminary evidence suggests that ITGB6 and ITGB8 are present on days 9, 12, and 15 
of porcine endometrium based on RT-PCR (Genbank accession # AY496298, 
AY496299).  Integrin subunits identified at the porcine conceptus-maternal interface 
occur as heterodimers that serve as receptors for ECM proteins including VN, FN, oFN, 
and SPP1, which are also present at the maternal-conceptus interface during the peri-
implantation period in pigs.  
LAP, a known ligand for integrins, has not been directly identified at the porcine 
conceptus-maternal interface.  However, in situ hybridization localization of TGFB at the 
conceptus-maternal interface suggests that LAP is present because the same gene 
produces TGFB and LAP, and TGFB is mostly secreted as the LLC.  In addition, LAP 
was detected in porcine uterine flushes on day 12 of pregnancy via western blots (Jaeger, 
unpublished).  If both LAP and ITGAV-containing heterodimers co-exist at the 
conceptus-maternal interface, they are potentially available to interact with each other.  
Interactions between TGFB, LAP, and integrins may be crucial during implantation.   
Adhesion assays utilizing pTr2 cells demonstrated that LAP-integrin binding is 
mediated via the RGD sequence in LAP.  In addition, culture dishes coated with LAP 
supported pTr2 adhesion, whereas, LAP in which the RGD sequence is mutated to RGE 
(LAP-RGE) failed to support adhesion.  Similarly, polystyrene beads coated with LAP or 
FN induced focal adhesions containing α-actinin and talin when deposited on the apical 
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surfaces of trophectoderm and uterine LE cells in vitro.  In support of this data, 
aggregation of α-actinin and talin were absent in the presence of control poly-l-lysine 
coated beads (Jaeger et al. 2005).  To date, there are limited reports of data supporting 
focal adhesion formation in vivo; however, aggregation of integrins in response to 
mechanosensation and mechanotransduction at the ovine conceptus-maternal interface 
was recently reported (Burghardt et al. 2009).  
Our hypothesis is that LAP binds to and activates ITGAV-containing 
heterodimers inducing integrin aggregation at the conceptus maternal interface and that 
these interactions are a functional component of implantation, particularly attachment of 
the conceptus to the uterine LE.  In addition, LAP-integrin interactions may play an 
important role in activating TGFB in conceptus and uterine tissues.  We also hypothesize 
that TGFB acting via TGFBRs have critical roles during preimplantation and 
implantation, and such roles may include promoting conceptus development and survival 
along with conceptus adhesion.  We have formulated two objectives to be accomplished 
in the course of this project.      
  
Objectives  
Objective 1 
Determine the temporal and spatial distribution of LAP, TGFB, and integrins 
during porcine peri-implantation.  Identify TGFB induced TGFBR activation, and 
determine which integrins expressed at the porcine conceptus-maternal interface 
specifically bind LAP.    
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Objective 2 
Determine effects of LAP and TGFB on conceptus development, conceptus 
survival, and implantation. 
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CHAPTER III 
PRESENCE OF TRANSFORMING GROWTH FACTOR BETA, LATENCY 
ASSOCIATED PEPTIDE, AND INTEGRINS IMPLIES LIGAND-RECEPTOR 
INTERATIONS DURING PORCINE IMPLANTATION 
 
Introduction 
 Implantation is a critical period during pregnancy that begins when the conceptus 
comes in close proximity to the uterine luminal epithelium (LE) to initiate the 
development of the conceptus-maternal interface (King et al. 1982).  Pigs are unique in 
that they have epitheliochorial implantation and their conceptuses undergo an 
exaggerated morphological transformation in which they elongate from 5 mm to 150 mm 
between days 10-12 of pregnancy (Geisert et al. 1982b).  By day 13 of pregnancy, 
porcine filamentous conceptuses begin to make initial attachments to the uterine LE, and 
by day 24, implantation is essentially complete resulting in the interdigitation of LE and 
the trophectoderm (Keys & King 1990).  Autocrine, paracrine, and juxtacrine signaling 
during the peri-implantation period are evident by the presence of many signaling 
molecules at the conceptus-maternal interface.  Alterations in these signaling processes 
can compromise implantation and contribute to reproductive failure.  In pigs, a significant 
proportion of pregnancy loss occurs during the peri-implantation period (Flint et al. 1982, 
Jainudeen & Hafez 1987).  Signaling molecules such as transforming growth factor betas 
(TGFBs) and integrins are among the various signaling molecules that have been reported 
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to be present in uterine and placental tissues prior to and during implantation in pigs 
(Bowen et al. 1996, Gupta et al. 1996, Gupta et al. 1998b, Burghardt et al. 2002).   
 The TGFB isoforms (TGFB1, 2 and 3) signal through TGFB receptor types I and 
II (TGFBR1 and TGFBR2).  TGFBs bind TGFBR2 and recruit TGFBR1 to the receptor 
ligand complex, ultimately causing serine and threonine transphosphorylation of 
TGFBR1 by TGFBR2 (Lin et al. 1992, Franzen et al. 1993, Wrana et al. 1994, Chen & 
Weinberg 1995).  TGFBR1 then phosphorylates the downstream effector SMAD 
(homologous of mothers against decapentaplegic in Drosophila and sma-2,-3, and -4 in 
C. elegans) proteins 2 and 3 at serine residues (Macias-Silva et al. 1996, Zhang et al. 
1996).  Phosphorylation-dependent conformational changes in SMAD2 and 3 enable 
heteromerization with SMAD4; the resultant SMAD complex then translocates into the 
nucleus (Nakao et al. 1997) where the combination of SMADs and cofactors within the 
transcriptional complex regulate transcriptional activity of target genes (Macias-Silva et 
al. 1996, Nakao et al. 1997).  
 The cell secretes latent TGFB as a homodimer containing a non-covalent 
association with its prepropeptide homodimer, latency associated peptide (LAP), in the 
form of the small latency complex (SLC) (Lawrence et al. 1984, Gentry et al. 1988).  The 
SLC further associates with latent TGFB binding proteins (LTBPs) to form a large latent 
complex (LLC) which is the predominant secreted form (Miyazono et al. 1988, Koli et 
al. 2001).  LTBPs serve to link the SLC to ECM proteins such as fibronectin and fibrillin-
1 via transglutaminase (Taipale et al. 1992, Nunes et al. 1997, Isogai et al. 2003).  
Conformational changes in the latent complex or dissociation of TGFBs from LAP 
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activate TGFB and allow it to become available for receptor interactions.  This activation 
occurs through multiple extracellular mechanisms which may involve proteases (Lyons et 
al. 1988, Rifkin et al. 1999, Annes et al. 2003, Jenkins 2008), thrombospondin-1 
(Crawford et al. 1998, Murphy-Ullrich & Poczatek 2000), and integrins (Munger et al. 
1999, Annes et al. 2002, Mu et al. 2002, Annes et al. 2003, Sheppard 2005).  Like many 
ECM proteins, LAP1 and 3 monomers, corresponding to respective TGFB1 and 3 
isoforms, contains an arginine-glycine-aspartate (RGD) site.  Previous studies have 
demonstrated that LAP binds to integrin heterodimers via this RGD sequence (Munger et 
al. 1998, Munger et al. 1999, Mu et al. 2002, Ludbrook et al. 2003). 
 Integrins are a family of transmembrane glycoprotein receptors that form non-
covalent alpha and beta heterodimers.  The 18 alpha and 8 beta subunits combine to form 
24 receptors that can sense external and internal cellular environments and function as 
receptors for specific ECM proteins (Hynes 1992) and cell surface proteins.  Several of 
the integrin receptors recognize and interact with the Arg-Gly-Asp (RGD) sequence on 
various ECM protein ligands (Ruoslahti 1996).  LAP binds to integrins αvβ1, αvβ3, 
αvβ5, αvβ6, αvβ8 and α8β1, most of which are implicated in TGFB activation (Munger et 
al. 1998, Munger et al. 1999, Annes et al. 2002, Lu et al. 2002, Mu et al. 2002, Asano et 
al. 2005b, Asano et al. 2005a).  Recent evidence provides insight that ITGAV (alpha V)-
containing integrin heterodimers mediate activation of TGFB and that this is of 
physiologic importance (Huang et al. 1996, Bader et al. 1998, Zhu et al. 2002, Yang et 
al. 2007).    
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  TGFBs, TGFBRs, and integrin (ITG) subunits ITGAV, ITGB1 (beta 1), ITGB3 
(beta 3), and ITGB5 (beta 5) were previously reported at the porcine conceptus-maternal 
interface (Bowen et al. 1996, Gupta et al. 1996, Gupta et al. 1998b, Burghardt et al. 
2002).  We hypothesize that active TGFBs and TGFBRs, along with LAP and integrins, 
functionally interact at the conceptus-maternal interface to mediate events essential to 
conceptus development and attachment in pigs.  Although the presence of TGFB and its 
receptors were separately reported during porcine implantation, evidence for their 
functional interactions was not determined.  In addition, the probability that LAP serves 
as an integrin ligand that subsequently affects receptor-ligand actions during porcine 
implantation has not been investigated.  The objective of this investigation was to 
investigate potential mechanistic roles for active and latent TGFB and integrins during 
porcine implantation.  Therefore, the present studies were designed to: 1) co-localize and 
identify the temporal and spatial distributions of TGFB, LAP and integrins in porcine 
implantation sites; 2) demonstrate that LAP directly binds to integrins on the surface of 
porcine conceptuses; and 3) demonstrate activation of TGFBRs through the presence of 
phosphorylated downstream effector SMAD2/3 in porcine conceptus and endometrium.   
 
Materials and Methods 
Animals  
 Experimental procedures were approved by Texas A&M University’s Animal 
Care and Use Committee (AUP # 2007-154).  Crossbred gilts were checked daily for 
estrus, and bred approximately 12 and 24 hours after their second detected estrus.  
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Ovariohysterectomies were performed on days 10, 12, 16, 20, and 24 of pregnancy (n=3 
gilts/day).  Prior to surgery, anesthesia was induced with an intramuscular injection of 
tiletamine hydrochloride and zolazepam hydrochloride (6.6 mg/kg, Telazol, Fort Dodge 
Animal Health, Fort Dodge Iowa) and was maintained with isoflurane (2-3% in oxygen).  
After removal of the uterus, day 10 and 12 conceptuses were flushed from each horn with 
10 mM Tris HCl pH 7.0 (25 ml/horn), and the uterine horns were opened along the anti-
mesometrial border.  Uterine and conceptus tissues were preserved by embedding in 
Tissue-Tek Optimal Cutting Temperature Compound (OCT, Miles, Inc, Onenta, NY) and 
freezing in liquid nitrogen.  Remaining uterine and conceptus tissues were preserved in 
phosphate buffered 4% paraformaldehyde (PAF) and embedded in paraffin.  After 
removal of the uterus on days 16, 20, and 24 of pregnancy, uterine horns were opened 
along the anti-mesometrial border and sections from attachment sites containing both 
uterine and conceptus tissues and non-attachment sites absent of conceptus tissues were 
dissected from the uterine horns. Attachment and non-attachment uterine sections were 
preserved using both methods stated above.  
 
Immunofluorescence Staining 
 Antibodies used for immunofluorescence staining included: goat anti-LAP (#AB-
246-NA) and chicken anti-TGFB (#AF-101-NA) from R&D Systems (Minneapolis, 
MN);  rabbit anti-ITGAV (#AB1930), ITGB1 (#AB1952), ITGB3 (#AB1932) and 
ITGB5 (#AB1926) integrin subunits from Chemicon (Temecula, CA); and rabbit anti- 
ITGB6 (beta 6, #SC15329) and ITGB8 (beta 8, #SC25714) integrin subunits from Santa 
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Cruz (Santa Cruz, CA).  Secondary antibodies used for immunofluorescence staining 
included FITC-conjugated rabbit anti-chicken, Texas Red-conjugated mouse anti-goat 
from Pierce Biotechnology Inc. (Rockford, IL) and FITC-conjugated donkey anti-rabbit 
from Southern Biotech (Birmingham, Alabama).      
 Discriminating between latent and active TGFB depends on specific antibodies, 
fixation methods, and tissue preparation (Barcellos-Hoff et al. 1994, Barcellos-Hoff et al. 
1995).  The double labeling protocol for latent TGFB (LAP) and active TGFB (TGFB, 
kindly provided by Barcellos-Hoff), was performed to ensure maximal discrimination of 
the antibodies for latent and active TGFB.  Anti-LAP detected dimeric and monomeric 
LAP from TGFB isoform 1 in western blotting.  In addition, anti-LAP was specific for 
latent TGFB1 immunostaining (Barcellos-Hoff et al. 1994, Ehrhardt et al. 1997).  Anti-
TGFB recognizes active TGFB1 not associated with LAP (Ehrhardt et al. 1997). 
 Frozen uterine and conceptus tissues were sectioned (8 µM), mounted on 
Superfrost Plus glass slides (Anapath, Cheyenne, WY), and immunofluorescent co-
localization of LAP and TGFB were performed as described by (Ewan et al. 2002) with 
minor modifications.  Sections were fixed with 2% PAF, washed with 0.1 M glycine in 
.02 M phosphate buffered saline (PBS), blocked with 0.5% casein in PBS, and incubated 
overnight at 4oC with TGFB and LAP primary antibodies at concentrations of 1.25 μg/ml 
and 15 μg/ml, respectively.  Controls included separate sections incubated with TGFB 
and irrelevant goat IgG; LAP and irrelevant chicken IgG; and with chicken IgG and goat 
IgG.  Sections were incubated with appropriate FITC- or Texas Red- conjugated 
secondary antibodies for 1 h at room temperature at a concentration of 3.75 μg/ml and 2.5 
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μg/ml, respectively.  Slides were overlaid with Prolong antifade mounting reagent 
containing the nuclear counterstain DAPI (Invitrogen, Molecular Probes, Eugene, OR) 
and then coverslipped.   
 Integrins were localized with LAP in frozen sections by immunofluorescence 
staining.  Sections were fixed and washed as described above then blocked in 10% 
normal goat and normal donkey sera.  Sections were incubated overnight at 4°C with 
anti-LAP IgG (15 μg/ml) along with each integrin subunit ITGAV, ITGB1, ITGB3, 
ITGB5, ITGB6, or ITGB8 primary antibody (5 μg/ml).  Controls included separate 
sections incubated with each anti-integrin subunit IgG and irrelevant goat IgG; anti-LAP 
IgG with irrelevant rabbit IgG; and rabbit IgG with goat IgG.  Sections were incubated 
with appropriate FITC- or Texas Red- conjugated secondary antibodies and coverslipped 
as described above.      
   
Immunohistochemistry 
 Rabbit anti-phosphorylated SMAD2/3 (p-SMAD2/3) from Santa Cruz was used 
for immunohistochemical staining.  Uterine and conceptus paraffin embedded tissues 
were sectioned (5 µM) and mounted on Superfrost plus slides.  Tissues were then 
deparaffinized with xylene and rehydrated through a graded series of alcohol.  
Endogenous peroxidase was blocked with 0.3% H2O2 in dH2O.  Sections were subjected 
to antigen retrieval with citrate buffer (pH 6.2) at 80°C for 45 min.  Sections were 
blocked with 10% normal goat serum at 25°C for 20 min, and incubated overnight at 4°C 
with primary antibody p-SMAD 2/3 (0.4 μg/ml) or control Rabbit IgG (0.4 μg/ml) in 2% 
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bovine serum albumin (BSA) in PBS (PBSA).  Sections were rinsed with PBSA and 
PBSA containing 1% Triton and incubated with biotinylated-conjugated secondary 
antibody diluted in PBSA containing 5% normal goat serum for 1 h at 25ºC.  Sections 
were then rinsed as described above, incubated in Vectastain ABC (Vector Laboratories, 
Burlingame, CA) for 30 min at room temperature, and then rinsed again with PBS and 
0.5 M Tris-HCl.  Immunoreactions were detected with peroxidase solution (DAB/H2O2) 
and stopped by submerging in H2O at 1.5 min after application of peroxidase solution.  
Sections were counterstained with Shandon Eosin-y aqueous (Thermo Scientific, 
Waltham, MA), rinsed with distilled water, dehydrated with the reverse series of graded 
alcohol, and covered slipped with Clarion Mounting Medium (Biomeda Corp, Foster 
City, CA).  
 
Photomicrography 
Representative immunofluorescence and immunohistochemistry images were 
collected and analyzed using an Axioplan 2 microscope (Carl Zeiss, Thornwood, NY) 
interfaced with an Axioplan HR digital camera and Axiovision 4.6 software.  Because of 
Axiovision’s multidimensional acquisition with individual fluorophore channels, each 
fluorophore was captured as separate channels, and both single and double labeled 
sections were visualized.  Images were converted to TIFF file format, and Adobe 
Photoshop CS2 (version 9.0, Adobe Systems Inc., San Jose, CA) was used to generate 
photographic composite images. 
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Biotinylation of apical proteins on cultured porcine trophectoderm cells 
 A porcine trophectoderm cell line (pTr2) was cultured as previously described 
(Ka et al. 2001) and kept in a 5% CO2 humidified environment.  Cells grown to 
confluence in 75 cm2  culture flasks were biotinylated on their apical surfaces, as 
previously described (Jaeger et al. 2005).  Cells were rinsed with Ca2+-Mg2+-free PBS 
following with a short incubation 5 mM EDTA for 60 seconds at room temperature and 
then rinsed with Ca2+-Mg2+-free PBS.  The apical surfaces were biotinylated with 0.25 
mg/ml of membrane impermeable biotin N-hydroxysulfosuccinimidobiotin, EZ-Link 
Sulfo-NHS-Biotin (Pierce Biotechnology, Inc) for 1 hr in the dark at room temperature.  
The reaction was stopped with 0.1 M glycine in PBS.  Cells were then lysed with 50 mM 
OSGP lysis buffer (1 mM each Ca2+/Mg2+/Mn2+ and 3 mM PMSF), and the monolayer of 
cells was scraped and passed through a 25 gauge needle.  Lysates were centrifuged 
(16,000 Xg) for 20 min at 4oC, and the supernatant was retained for subsequent affinity 
chromatography and immunoprecipitation.    
 
Affinity Chromatography and Immunoprecipitations 
 Recombinant simian LAP, produced by Sf9 insect cells (Invitrogen, Carlsbad, 
CA) infected with a recombinant baculovirus (generously provided by Dr. J.S. Munger, 
New York University School of Medicine, New York, NY) and purified as previously 
described (Munger et al. 1998), was dialyzed using Slide-A-Lyzer dialysis cassette 
(Pierce Biotechnology, Inc) as per manufacturer’s instructions.  LAP (4.3 mg) was 
coupled to cyanogen bromide-activated sepharose (Sigma #c9142) as per manufacturer’s 
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instructions.  A small sample of LAP coupled with sepharose beads was subjected to 12% 
reducing and non-reducing SDS-PAGE to verify that sepharose beads were coupled with 
non-denatured LAP.  In the presence of cations (Mg2+ and Mn2+), surface biotinylated 
pTr2 cells were added to the column containing sepharose beads coupled with LAP and 
incubated for 2 h on ice.  Columns were washed with TBS containing 3% OG, 1.5 mM 
Mg2+, and 1.5 mM Mn2+; and TBS containing 1% OG, 1.5 mM Mg2+, and 1.5 mM Mn2+.  
Eight fractions (0.5 ml/fraction) were eluted with 1% OG in TBS and 10 mM EDTA.  
Eluate fractions were run on a 7.5% non-reducing SDS-PAGE, blotted to nitrocellulose, 
blocked with 5% BSA in TBS containing 0.03% Tween (TBST) for 30 min at room 
temperature, and incubated with ABC reagent for 30 min at room temperature to detect 
biotinylated proteins.  Blots were visualized with chemiluminescent detection reagent, 
SuperSignal West Pico Substrate (Pierce Biotechnology, Inc.) and captured using a 
Fluorochem 8800 imager (AlphaInnotech; San Leandro, CA).              
 Eluate fractions containing biotinylated proteins were concentrated using 
Centriprep Centrifugal Filter Device (Millipore Corporation, Billerica, MA).  Eluate 
fractions were immunoprecipitated with antibodies to integrin subunits (ITGAV, ITGB1, 
ITGB3, ITGB5, ITGB6, or ITGB8) or normal rabbit serum control at a concentration of 
2.5 μg/ml and A-protein G agarose conjugated beads (Santa Cruz Biotechnology) as 
previously described (Jaeger et al. 2005).  Briefly, eluates were pre-cleared with normal 
rabbit serum and A-protein G agarose and incubated with anti-integrin subunits or control 
IgG overnight with end over end rotation at 4ºC.  A-protein G agarose beads were 
washed with RIPA buffer (0.02M PBS containing 1% IGEPAL, 0.5% sodium 
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deoxycholate, and 0.1% SDS), were run on a 7.5% reducing SDS-PAGE, blotted, and 
visualized as described.      
 
Results 
 When TGFB is associated with its prepropeptide LAP, it can not bind TGFB 
receptors and therefore is called latent TGFB. The antibody to LAP detects both LAP1 
alone as well as latent TGFB1 (LAP). The TGFB antibody detects only TGFB1 that is 
not associated with LAP, which is termed active TGFB1 (TGFB).  Co-localization 
ensures discrimination between latent and active TGFB (For detailed description see 
Materials and Methods). 
  
Distribution of LAP and TGFB  
 On days 10 to 16 of pregnancy, LAP (Texas Red) and TGFB (FITC) were 
detected primarily on the surfaces of conceptus trophectoderm, endometrial LE, and 
endometrial glandular epithelium (GE).  Trophectoderm, LE, and GE immunostaining 
gradually increased from days 10 through 16 and became more apical in distribution 
(Figure 3.1).  By day 16, LAP and TGFB were also prominently expressed at the basal 
surface of endometrial epithelia.  In addition, TGFB was detectable in endometrial stroma 
and blood vessels by day 10 and increased by day 16, whereas, LAP was first detected in 
these tissues by day 16 of pregnancy (Figure 3.1).  Significant co-localization of LAP 
and TGFB, (appearing yellow in color in image overlays), was detected along all 
trophectoderm and was greatest at apical surfaces of trophectoderm and LE on day 16 of
  Figure 3.1.  Distribution of TGFB and LAP during Porcine Implantation.   Immunofluorescence co-localization of TGFB 
with LAP in frozen cross-sections of day 10 and 12 pregnant pig endometrium and conceptuses, and day 16 and 20 conceptus 
attachment sites.  TGFB immunoreactivity was detected using FITC-conjugated anti-chicken IgG (middle column of each 
quadrant; green fluorescence), whereas LAP immunoreactivity was detected using Texas Red-conjugated anti-goat IgG (left 
column of each quadrant; red fluorescence).  Yellow immunofluorescence indicates co-localization of TGFB with LAP (right 
column of each quadrant).  Compare the antibody staining with staining using chicken and goat IgG (Fig. 2; bottom row).  LE, 
luminal epithelium; GE, glandular epithelium; Tr, trophectoderm. Width of fields are 230 µm. 
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pregnancy (Figure 3.1).  By day 20 of pregnancy, LAP immunostaining at the conceptus-
maternal interface decreased; however, a striking punctate pattern for TGFB 
immunostaining was detected at the apical surfaces of LE and trophectoderm (Figure 
3.1).  Further, intense immunostaining for LAP was observed at apical surfaces of GE, 
and this co-localized with lower levels of TGFB immunostaining (Figure 3.1).  Uterine 
sections devoid of conceptus tissues (non-attachment sites) from day 16 and 20 of 
pregnancy displayed variable immunostaining for LAP and TGFB (data not shown).   
 During the later stages of implantation (day 24 of pregnancy), a dramatic shift in 
the presence of LAP and TGFB was observed.  Large aggregates of LAP were prominent 
at the apical surfaces of LE and trophectoderm at the conceptus-maternal interface.  In 
contrast, TGFB immunostaining markedly decreased by day 24 of pregnancy (Figure 
3.2).  Similar to what was observed at day 20 attachment sites, intense LAP was detected 
at the apical surfaces of GE however, instead of uniform immunostaining, LAP was 
detected in aggregates (Figure 3.2).  Low intensity immunostaining for TGFB was 
detected on the apical surfaces of GE, and low levels of LAP and TGFB co-localization 
were evident (Figure 3.2).  The intensity of LAP and TGFB immunostaining was 
markedly lower on day 24 at non-attachment sites compared to attachment sites.  At non-
attachment sites on day 24, aggregates of LAP were no longer evident along the luminal 
surfaces; however, some aggregates were detected along the apical surfaces of GE 
(Figure 3.2).        
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Figure 3.2.  Distribution of TGFB and LAP during Porcine Implantation.  
Immunofluorescence co-localization of TGFB with LAP in day 24 frozen cross-sections 
of pig implantation (top row) and non implantation (middle row) sites.  TGFB 
immunoreactivity was detected using FITC-conjugated anti-chicken IgG (middle column; 
green fluorescence), whereas LAP immunoreactivity was detected using Texas Red-
conjugated anti-goat IgG (left column; red fluorescence).  Yellow immunofluorescence 
indicates co-localization of TGFB with LAP (right column).  Compare the antibody 
staining with staining using chicken and goat IgG (bottom row).  LE, luminal epithelium; 
GE, glandular epithelium; Tr, trophectoderm. Width of fields are 230 µm.
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Detection of p-SMAD2/3 Implies Functional TGFB During Implantation 
 SMAD proteins 2 and 3 are phosphorylated in response to TGFB interacting with 
TGFBRs.  Therefore, immunohistochemical analysis of p-SMAD2/3 was performed on 
conceptus and uterine tissues to evaluate functional interactions between TGFBs and 
TGFBRs during porcine implantation.  On all days of the peri-implantation period (10 
through 24) p-SMAD2/3 was detected in nearly all the nuclei of endometrial LE, GE, 
fibroblasts, and endothelia in both attachment and non-attachment sites (Figure 3.3).  In 
conceptus tissues, p-SMAD2/3 was detected in the trophectoderm of free floating 
spherical and filamentous conceptuses as well as at conceptus attachment sites.  At all 
days, p-SMAD2/3 immunohistochemical staining appeared more intense in the 
trophectoderm compared to in the uterine epithelium (Figure 3.3).   
  
Integrin Subunits and LAP Are Available for Receptor Ligand Interaction During 
Implantation 
  Immunofluorescence analyses were used to co-localize integrin subunits ITGAV, 
ITGB1, ITGB3, ITGB5, ITGB6, or ITGB8 (FITC) with LAP (Texas Red) on day 10 and 
12 pre-implantation uterine tissues and on day 16, 20, and 24 conceptus attachment and 
non-attachment sites.  On all days observed, immunostaining intensities for ITGB6 and 
ITGB8 were low and, in some cases, undetectable (Figures 3.4-3.7).  On days 10 through 
16, ITGB6 immunostaining was slightly higher in GE compared to LE; whereas, ITGB8 
was slightly higher in LE as compared to GE.  Both ITGB6 and ITGB8 were 
undetectable by day 20 of pregnancy (Figures 3.4-3.7). 
 
  Figure 3.3.  Detection of p-SMAD2/3 Implies Functional TGFB during Implantation.  Immunohistochemical 
localization of p-SMAD2/3 protein in paraffin-embedded uterine cross-sections from day 10 and 12 pregnant pig endometrium 
and conceptuses, and day 16 and 20 conceptus attachment sites, and day 24 conceptus attachment and non attachment sites.  
The brown color indicates positive immunostaining for p-SMAD2/3.  All sections were counterstained with Shandon Eosin-y 
aqueous.  Sections stained with nonimmune rabbit IgG serve as negative controls.  LE, luminal epithelium; GE, glandular 
epithelium; Tr, trophectoderm.  Width of fields are 230 µm. 
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 Figure 3.4. Integrin Subunits and LAP Are Available for Receptor Ligand Interaction on Day 12 of Pregnancy.  
Immunofluorescence co-localization of integrin subunits (ITGAV, ITGB1, ITGB3, ITGB5, ITGB6, ITGB8) with LAP in 
frozen cross-sections of day 12 pregnant pig endometrium.  Integrin subunit immunoreactivity was detected using FITC-
conjugated anti-rabbit IgG (columns 1 and 4; green fluorescence), whereas LAP immunoreactivity was detected using Texas 
Red-conjugated anti-goat IgG (columns 2 and 5; red fluorescence).  Yellow immunofluorescence indicates co-localization of 
integrin subunit with LAP (columns 3 and 6).  Compare the antibody staining with staining using rabbit and goat IgG (bottom 
row).  LE, luminal epithelium; GE, glandular epithelium. Width of fields are 230 µm. 
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Figure 3.4. Continued
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 Figure 3.5. Integrin Subunits and LAP Are Available for Receptor Ligand Interaction at Conceptus Attachment Sites 
on Day 16 of Pregnancy.  Immunofluorescence co-localization of integrin subunits (ITGAV, ITGB1, ITGB3, ITGB5, ITGB6, 
ITGB8) with LAP in frozen cross-sections of day 16 pig conceptus attachment sites.  Integrin subunit immunoreactivity was 
detected using FITC-conjugated anti-rabbit IgG (columns 1 and 4; green fluorescence), whereas LAP immunoreactivity was 
detected using Texas Red-conjugated anti-goat IgG (columns 2 and 5; red fluorescence).  Yellow immunofluorescence 
indicates co-localization of integrin subunit with LAP (columns 3 and 6).  Compare the antibody staining with staining using 
rabbit and goat IgG (Fig. 4; bottom row).  LE, luminal epithelium; GE, glandular epithelium; Tr, trophectoderm. Width of fields 
are 230 µm.
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Figure 3.5. Continued
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 Figure 3.6.  Integrin Subunits and LAP Are Available for Receptor Ligand Interaction at Conceptus Attachment Sites 
on Day 20 of Pregnancy.  Immunofluorescence co-localization of integrin subunits (ITGAV, ITGB1, ITGB3, ITGB5, ITGB6, 
ITGB8) with LAP in frozen cross-sections of day 20 pig conceptus attachment sites.  Integrin subunit immunoreactivity was 
detected using FITC-conjugated anti-rabbit IgG (columns 1 and 4; green fluorescence), whereas LAP immunoreactivity was 
detected using Texas Red-conjugated anti-goat IgG (columns 2 and 5; red fluorescence).  Yellow immunofluorescence 
indicates co-localization of integrin subunit with LAP (columns 3 and 6).  Compare the antibody staining with staining using 
rabbit and goat IgG (Fig. 4; bottom row).  LE, luminal epithelium; GE, glandular epithelium; Tr, trophectoderm. Width of fields 
are 230 µm.
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Figure 3.6. Continued
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 Figure 3.7.  Integrin Subunits and LAP Are Available for Receptor Ligand Interaction at Conceptus Attachment Sites 
on Day 24 of Pregnancy.  Immunofluorescence co-localization of integrin subunits (ITGAV, ITGB1, ITGB3, ITGB5, ITGB6, 
ITGB8) with LAP in frozen cross-sections of day 24 pig conceptus attachment sites.  Integrin subunit immunoreactivity was 
detected using FITC-conjugated anti-rabbit IgG (columns 1 and 4; green fluorescence), whereas LAP immunoreactivity was 
detected using Texas Red-conjugated anti-goat IgG (columns 2 and 5; red fluorescence).  Yellow immunofluorescence 
indicates co-localization of integrin subunit with LAP (columns 3 and 6).  Compare the antibody staining with staining using 
rabbit and goat IgG (Fig. 4; bottom row).  LE, luminal epithelium; GE, glandular epithelium; Tr, trophectoderm. Width of fields 
are 230 µm.
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Figure 3.7. Continued 
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Immunostaining for ITGAV was detectable on all endometrial and conceptus tissues 
from days 10 through 24.  Expression in LE and GE increased and became more apical in 
distribution by day 16, further increased at the conceptus-maternal interface by day 20, 
and these levels were maintained through day 24 (Figures 3.4-3.7).  Immunostaining for 
ITGB3 was detectable, but low, in all endometrial and conceptus tissues from days 10 
through 20.  Interestingly, by day 24, ITGB3 became more apical in distribution in GE, 
but formed intermittent aggregates at the conceptus-maternal interface (Figures 3.4-3.7).   
  Immunostaining for ITGB1 and ITGB5 were similar in intensity to that of 
ITGAV on all conceptus and endometrial tissues on days 10 though 16 with the exception 
of ITGB5 which showed a more apical distribution than the other integrins.  By day 20 of 
pregnancy, both ITGB1 and ITGB5 formed large distinct aggregates particularly in the 
LE at the conceptus-maternal interface which were maintained through day 24 (Figures 
3.4-3.7).  These aggregates likely represent a response to ligand binding and assembly of 
focal adhesions that serve to attach trophectoderm to luminal epithelium for stable 
attachment. These are the first results to show evidence of ITGB1 and ITGB5 induced 
focal adhesions at the conceptus-maternal interface in pigs.  Figure 3.8 shows 
immunostaining for ITGAV, ITGB1, ITGB3, ITGB5, ITGB6, and ITGB8 at day 24 non-
attachment sites. Note the absence of integrin aggregation at the apical surface of LE, 
strongly suggesting that aggregates form in response to trophectoderm attaching to 
luminal epithelium. 
 As noted previously, LAP was present in LE, GE, and trophectoderm in all tissues 
observed, and LAP immunostaining increased at the conceptus-maternal interface by day
 
 Figure 3.8. Integrin Subunits and LAP Are Available for Receptor Ligand Interaction at Non-Attachment Sites on Day 
24 of Pregnancy.  Immunofluorescence co-localization of integrin subunits (ITGAV, ITGB1, ITGB3, ITGB5, ITGB6, ITGB8) 
with LAP in frozen cross-sections of day 24 pig non attachment sites.  Integrin subunit immunoreactivity was detected using 
FITC-conjugated anti-rabbit IgG (columns 1 and 4; green fluorescence), whereas LAP immunoreactivity was detected using 
Texas Red-conjugated anti-goat IgG (columns 2 and 5; red fluorescence).  Yellow immunofluorescence indicates co-
localization of integrin subunit with LAP (columns 3 and 6).  Compare the antibody staining with staining using rabbit and goat 
IgG (Fig. 4; bottom row).  LE, luminal epithelium; GE, glandular epithelium. Width of fields are 230 µm.
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Figure 3.8. Continued
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 24 of pregnancy (Figures 3.4-3.7).  In contrast to integrins, LAP appeared to be 
distributed in the matrix that resides between the trophectoderm and LE, and did not 
precisely co-localize with aggregates of ITGB1 and ITGB5.  Therefore, the presence of 
LAP in the matrix between trophectoderm and LE perfectly places this protein to bind 
ITGB1, ITGB3, and ITGB5 integrins and stimulate the assembly of focal adhesions.  
 
LAP binds to surface biotinylated integrins expressed on pTr2 cells via the RGD site  
 Biotinylated proteins from the apical surfaces of pTr2 cells were subjected to 
affinity chromatography with sepharose beads carrying LAP.  Eluted proteins were 
separated on a non-reducing 7.5% SDS-PAGE gel.  This resulted in biotinylated protein 
bands of approximately 150 kDa and 100 kDa.  The molecular weight of 150 kDa 
corresponded with the known molecular weights of the non-reduced ITGAV subunit.  
The molecular weight of 100 kDa was within the range of multiple beta integrin subunits 
including ITGB1, ITGB3, ITGB5, ITGB6, and ITGB8 (Figure 3.9A).   
 Immunoprecipitations performed on these eluates using antibodies directed 
against integrin subunits ITGAV, ITGB1, ITGB3, ITGB5, ITGB6, and ITGB8 
successfully confirmed binding of each of these integrin subunits to LAP.  ITGAV, 
ITGB3, ITGB5, ITGB6, and ITGB8 immunoprecipitates yielded a band at 125 kDa 
corresponding to the known reduced molecular weight of ITGAV (Figure 3.9B).  
ITGAV immunoprecipitates also yielded a broad band at approximately 100 kDa 
corresponding to the beta subunit of the heterodimer.  ITGB1 has a reduced molecular 
weight of 130 kDa, and the ITGB1 immunoprecipitates yielded 2 bands in the range of
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Figure 3.9. LAP Binds to Surface Biotinylated Integrins Expressed on pTr2 Cells 
via the RGD Site.  A, pTr2 cells were surface labeled with biotin and detergent extracts 
of the cells were prepared and subjected to affinity chromatography as described in the 
Methods.  EDTA eluate fractions (E1-E8) were separated by 7.5% SDS-PAGE under non 
reducing conditions, transferred to nitrocellulose, and probed for biotin using ABC.  B, 
Eluate fractions containing biotinylated proteins were pooled.  Proteins were 
immunoprecipitated with antibodies to integrin subunits (ITGAV, ITGB1, ITGB3, 
ITGB5, ITGB6, or ITGB8) or rabbit IgG control and A-protein G agarose conjugated 
beads.  Immunoprecipitates were separated by 7.5% SDS-PAGE under reducing 
conditions, transferred to nitrocellulose, and probed for biotin using ABC. 
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125 kDa to 130 kDa, which are likely both ITGAV (125 kDa) and ITGB1 (130 kDa) 
subunits.  ITGB3 and ITGB5 immunoprecipitates yielded a diffuse band in the range of 
110 kDa to 130 kDa.  ITGB6 and ITGB8 immunoprecipitates yielded bands in the range 
of 95 kDa to 110 kDa (Figure 3.9B).               
  
Discussion  
 Results of the present study in pigs provide evidence that: 1) latent and active 
TGFB are present in conceptus and endometrium during the porcine peri-implantation 
period; 2) TGFB is functional in both conceptus and endometrial tissues; and 3) LAP is a 
ligand for ITGAV-containing heterodimers in conceptus trophectoderm during the peri-
implantation period.  Our detection of LAP in conceptus and endometrial tissues, along 
with earlier data (Gupta et al. 1996, Gupta et al. 1998b), support the finding that both the 
conceptus and uterus are sources of secreted TGFB.  Further, abundant LAP 
immunostaining detected on the apical surfaces of GE on days 16 and 20 of pregnancy 
suggests that the GE secrete latent TGFB as a component of histotroph.  Detection of 
abundant active TGFB at the apical surfaces of day 12 trophectoderm and conceptus-
maternal interface on days 16 and 20 suggests that TGFB is activated predominantly at 
the apical surfaces of filamentous conceptuses and at the conceptus-maternal interface.  
While activation of latent TGFB appears to occur primarily at sites of conceptus 
attachments, TGFB binds and activates TGFBRs at both attachment and non-attachment 
sites, as indicated by the detection of p-SMAD2/3 at both conceptus attachment and non-
attachment sites during porcine implantation.      
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  Large aggregates of LAP and low levels of TGFB immunostaining at the 
conceptus-maternal interface during the late stages of porcine implantation suggest 
sequestration of latent TGFB as a reservoir.  Despite low levels of TGFB 
immunostaining, detection of abundant p-SMAD2/3 at the conceptus-maternal interface 
provides evidence for the maintenance of functionally active TGFB during the later 
stages of implantation. While large aggregates of LAP may still represent a reservoir for 
latent TGFB at the conceptus-maternal interface, particularly along apical surfaces of GE, 
it is also likely that LAP functions as an adhesion molecule promoting attachment of the 
conceptus to the uterine LE via binding to integrin receptors at the conceptus-maternal 
interface.  Indeed, affinity chromatography results demonstrate that LAP binds to the 
integrin subunits ITGAV, ITGB1, ITGB3, ITGB5, ITGB6, and ITGB8 on the surfaces of 
porcine trophectoderm cultured cells.  These results, along with the detection of integrin 
aggregation at the conceptus-maternal interface, provide mechanistic and functional 
evidence for the hypothesis that LAP binding to ITGAV-containing integrin heterodimers 
serves as an adhesion complex that promotes and stabilizes conceptus attachment to the 
uterine LE during porcine implantation.   
 
Integrin Aggregation at the Porcine Conceptus-Maternal Interface 
 Aggregation of integrins in response to mechanosensation and 
mechanotransduction at the conceptus-maternal interface in sheep was recently reported 
(Burghardt et al. 2009).  However, this is the first report of ITGB1 and ITGB5 
aggregation at the conceptus-maternal interface during porcine implantation.  Upon 
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binding of ECM proteins, integrins aggregate to enhance signal transduction and form 
cytoplasmic focal adhesions that associate with the actin cytoskeleton (Wozniak et al. 
2004).  Formation of focal adhesions stabilizes cell attachments to the ECM by 
connecting ECM proteins to the actin cytoskeleton via actin filaments that can further 
assemble into contractile stress fibers (Bershadsky et al. 2006a).  In addition to 
transmitting force at cell adhesion sites, focal adhesions serve as signaling centers from 
which numerous intracellular pathways can regulate cell growth, proliferation, survival, 
gene expression, development, tissue repair, migration and invasion.  At least 156 
components including classes of receptor kinases, cytoskeletal proteins, and signaling 
molecules that involve up to 690 interactions have been identified at integrin adhesion 
sites characterized by focal adhesions (Zaidel-Bar et al. 2007).  Focal adhesions formed 
by in vitro cell cultures respond to intracellular forces generated by actin-myosin 
interaction or applied externally to the cell through the extracellular matrix by altering the 
size of focal adhesion and their composition (Galbraith et al. 2002).  Integrin 
immunostaining at porcine conceptus attachment sites identified intense and intermittent 
immunoreactive aggregates of integrin subunits ITGB1, ITGB5 and later ITGB3.  
Detection of integrin aggregation at the conceptus-maternal interface beginning by day 
20 of pregnancy implies that integrins bind to ECM proteins such as LAP to induce 
integrin aggregation and focal adhesion assembly that stabilizes adhesion of the 
conceptus to uterine LE during porcine implantation.  Interestingly, ITGB3 aggregates 
were not detected until day 24 of pregnancy and, similar to ITGB1 and ITGB5, these 
aggregates were not found at non-attachment sites.  Upregulation of ITGB3 integrin 
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subunit, possibly as the αvβ3 heterodimer, on the apical surfaces at the conceptus-
maternal interface may be important for further supporting conceptus adhesion.  Changes 
in the integrin repertoire on LE, particularly with αvβ3, have been detected during 
implantation in other species and are associated with stabilizing stronger conceptus 
adhesions (Johnson et al. 2001, Burghardt et al. 2002, Lessey 2002, Armant 2005, 
Burghardt et al. 2009).  During porcine implantation, αvβ1 and αvβ5 may play important 
roles for stabilizing initial attachments of the conceptus to the LE, and as implantation 
progresses αvβ1, αvβ5, and αvβ3 may be necessary to support stronger placental 
attachments.  
 
TGFB Activation via Integrins During Porcine Implantation  
 The presence of active TGFB and p-SMAD2/3 provides strong evidence that 
TGFB is activated throughout the porcine peri-implantation period.  Proteases such as 
plasmin and MMPs can activate TGFB; however, integrins also activate TGFB in vivo 
(Sato & Rifkin 1989, Lyons et al. 1990, Shull et al. 1992, Taipale et al. 1992, Huang et 
al. 1996, Bader et al. 1998, Yu & Stamenkovic 2000, Zhu et al. 2002, Jenkins 2008).  
More recently, transgenic mice, in which the RGD sequence in LAP is mutated to RGE, 
were shown to be phenotypically similar to TGFB1 null mice, further supporting the 
suggestion that integrin binding of LAP plays a significant role in activating TGFB in 
vivo (Yang et al. 2007).  This process of TGFB activation via integrins can result from 
conformational changes in the latent complex.  Activation of TGFB via αvβ3, αvβ5, 
αvβ6, and an as yet unidentified ITGB1 heterodimer occurs if TGFB is part of the large 
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latent complex (LLC) (Annes et al. 2004, Wipff & Hinz 2008).  LAP associated with the 
LLC binds integrins that are linked to the actin cytoskeleton; and since integrins can 
sense and respond to intracellular forces generated through the actin cytoskeleton and 
extracellular forces such as ECM rigidity, it is hypothesized that integrins can activate 
TGFB via traction forces (Keski-Oja et al. 2004, Larson et al. 2006).   
 Abundant active TGFB immunostaining was detected along the apical surfaces of 
filamentous conceptuses by day 12 of pregnancy and at the conceptus-maternal interface 
beginning by day 16 of pregnancy, suggesting that activation occurs along these surfaces.  
LAP and integrin subunits ITGAV, ITGB1, ITGB3, ITGB5, and low levels of ITGB6 
and ITGB8 were detected along the uterine LE, and integrins αvβ3, αvβ5, αvβ6, and 
possibly αvβ1, have been determined to activate latent TGFB by mechanical forces such 
as cellular contraction and external stretching (Jenkins et al. 2006, Wipff & Hinz 2008).  
Both of these mechanisms require: a) latent TGFB of the LLC tethered to an ECM that 
resists traction forces exerted on the LLC, b) LAP bound to integrin receptors, and c) 
presence of the actin cytoskeleton to generate force or provide resistance to extracellular 
forces (Wipff & Hinz 2008).  Such mechanisms of TGFB activation may occur at the 
porcine conceptus-maternal interface. 
 During porcine implantation, the conceptus migrates along the uterine epithelium 
that lines the uterine horns, and along these surfaces, the migrating conceptus may be a 
source of external force applied to the LAP-integrin adhesion complex.  We hypothesize 
that the apically bound LAP-integrin adhesion complex, in addition to supporting 
conceptus attachments, can also activate TGFB by inducing conformational changes in 
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the latent complex.  The conformational change generated by conceptus movement along 
the uterine LE may cause external stretch on the LLC and therefore liberate TGFB 
(Figure 3.10).   
 Intracellular forces may also play a role in activating TGFB during porcine 
implantation.  It is noteworthy that the subepithelial stroma of pigs undergoes remodeling 
during pregnancy that is associated with the upregulation of α-smooth muscle actin 
(ACTA2) within myofibroblast-like stromal cells (Johnson et al. 2003).  Increased ECM 
and incorporation of ACTA2 into stress fibers significantly augments the contractile 
activity of fibroblastic cells and are hallmarks of connective tissue remodeling (Hinz et 
al. 2001) which is expected to take place in a mechanically stressed environment such as 
the uterine wall during pregnancy.  Cellular contraction mediated by the cross bridging 
ACTA2 and myosin is involved in balancing mechanical forces placed on the ECM.  
These contractile forces have previously been shown to activate TGFB in myofibroblast 
cultures (Wipff et al. 2007).   It is possible that in the porcine uterus, contraction of the 
actin filaments associated with integrins generates a force on the LAP- integrin complex, 
causing a conformational change in the LLC, and liberating TGFB from its latent 
complex.  As reported here, latent TGFB localized within the ECM of the stroma during 
porcine implantation may be subjected to activation by integrins transmitting intracellular 
mechanical forces. 
   We propose therefore that ITGAV-containing heterodimers participate in TGFB 
activation during porcine implantation via mechanisms including, but not limited to, 
traction forces.  Forces generated by the conceptus may be a mechanism for activating
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Figure 3.10. Proposed Model of External Forces Activate TGFB at the Conceptus-
Maternal Interface.  A, Integrin heterodimers on porcine trophectoderm (Tr) and uterine 
LE bind to LAP via its RGD sequence serving to support conceptus attachment to the LE 
during porcine implantation.  B, LAP bound to integrins αvβ3, αvβ5, αvβ6, and possibly 
αvβ1 may serve to activate TGFB.  External force, such as the conceptus migrating along 
the apical surfaces of the LE, is exerted on the LAP-integrin adhesion complex.  LAP 
tethered to the ECM via LTBP along with integrins associated with the actin cytoskeleton 
both resists extracellular forces exerted on the complex, resulting in a conformational 
change in latent TGFB.  TGFB is liberated from the latent complex and is available to 
bind to TGFBR on porcine Tr and uterine LE.
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TGFB at sites of conceptus contact, and forces generated from within the cell may be a 
mechanism for activating TGFB within the endometrial stroma.  Active TGFB can 
therefore, bind and activate TGFBRs at both conceptus attachment and non-attachment 
sites.   
 
Potential Roles for TGFB During Porcine Implantation 
 In other species, TGFB has been linked to indirect role(s) in trophoblast 
attachment and invasion by enhancing production of ECM proteins such as oncofetal-
fibronectin (oFN) (Feinberg et al. 1994), inducing expression of integrins (Zambruno et 
al. 1995, Kagami et al. 1996, Lai et al. 2000, Pechkovsky et al. 2008), and inhibiting 
trophoblast invasion by reducing production of proteases such as MMPs and plasmin 
(Graham & Lala 1991, Graham 1997, Kallapur et al. 1999, Karmakar & Das 2002).  
Similar actions of TGFB may also be involved in peri-implantation events in pigs.  Based 
on p-SMAD2/3 localization in pigs, TGFB appears to initiate intracellular signaling 
within conceptus and uterine tissues, possibly regulating transcription of genes involved in 
porcine implantation. 
 In summary, in vivo results support the conclusion that latent TGFB is secreted 
and activated during the porcine peri-implantation period, LAP binds integrins and may 
aid in TGFB activation as well as promote conceptus attachment, and signaling through 
SMADs is present in both conceptus and uterine tissues.  Our results provide evidence for 
functional TGFB and integrin activation during the porcine peri-implantation period.  
Furthermore, LAP binding to integrins at the porcine conceptus-maternal interface may 
induce integrin aggregation of ITGB1, ITGB3, and ITGB5 integrin subunits aiding in 
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strong conceptus attachment to the uterine LE.  We are the first to report aggregation of 
integrin subunits ITGB1 and ITGB5 suggesting formation of focal adhesions at the 
conceptus-maternal interface in pigs.  In addition the LAP-integrin adhesion complex may 
be subjected to, but not limited to, traction forces causing activation of latent TGFB at the 
conceptus-maternal interface during porcine implantation.  TGFB activating TGFBR 
downstream signaling molecules may have roles in promoting conceptus attachment by 
upregulating pro-adhesive molecules such as integrins and oFN, and inhibiting conceptus 
invasion by decreasing production of proteases.  The interrelationships between TGFB 
and integrins described here are likely an important part of the complex networking 
system of interplay between the conceptus and uterus during the porcine peri-implantation 
period.           
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CHAPTER IV 
INTRAUTERINE INFUSION OF LATENCY ASSOCIATED PEPTIDE (LAP) 
DURING EARLY PORCINE PREGNANCY AFFECTS CONCEPTUS 
ELONGATION AND PLACENTAL SIZE 
 
Introduction 
 Mechanisms supporting conceptus elongation and attachment during porcine 
pregnancy are largely unknown, but altering the uterine environment during the peri-
implantation period may alter conceptus development and survival (Wilson et al. 2001).  
During this critical period, cross-talk between the conceptus and uterus mediates 
conceptus development and implantation, and crosstalk asynchrony may result in 
conceptus mortality (Pope et al. 1982, Pope et al. 1986, Geisert et al. 2006).  
Implantation in pigs is superficial, and prior to attachment, conceptuses undergo 
transformations from spherical (5 mm) to filamentous (150 mm) forms between days 10-
12 of pregnancy (Geisert et al. 1982b).  In a receptive uterine environment, filamentous 
conceptuses begin to make initial attachments to the uterine luminal epithelium (LE) by 
day 13 of pregnancy.  Porcine implantation is essentially complete by day 24 of 
pregnancy, resulting in interdigitation of LE and the trophectoderm (Keys & King 1990).  
Signals initiating conceptus elongation, and mechanisms supporting conceptus 
development and implantation in pigs, remain largely unknown.  
   Experimental intrauterine infusions with implantable osmotic pumps have been 
used to study development of the conceptus, physiology of the uterus, pathogenesis of 
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reproductive infections, and, to a limited extent, to deliver substances to uteri of 
domestic livestock (Pratt et al. 1979, Ayad et al. 1993, Vanderwall et al. 1994, Joyce et 
al. 2007a).  Such experimental infusions have not been used to investigate conceptus 
development and attachment during the peri-implantation period in pregnant swine.  
Establishing a delivery system that remains contained within the abdominal cavity and 
enables controlled delivery of substances to the uterine lumen of pregnant gilts, while 
allowing maintenance of pregnancy, would be a novel way to alter in vivo basal levels of 
signaling proteins proposed to be involved in mediating porcine conceptus development 
and attachment.        
 Transforming growth factor beta (TGFB), TGFB receptors (TGFBRs), and 
integrins may contribute to the events of porcine implantation (Bowen et al. 1996, Gupta 
et al. 1996, Gupta et al. 1998a, Gupta et al. 1998b, Burghardt et al. 2002).  TGFB 
homodimers are secreted by the cell in latent complexes, which include prepropeptide 
latency associate peptides (LAP), with which the homodimers are non-covalently 
associated.  These complexes further associate with latent TGFB binding proteins 
(LTBPs), which can sequester the inactive growth factor to the extracellular matrix 
(ECM) (Lawrence et al. 1984, Gentry et al. 1988, Miyazono et al. 1988).  Activation of 
latent TGFB must occur prior to TGFB signaling through TGFBRs.  Activation of 
TGFBRs results in phosphorylation of downstream effector SMAD proteins 2 and 3 (p-
SMAD2/3) and subsequent translocation of the phosphorylated SMADs into the nucleus 
with SMAD4.  The combination of SMADs and cofactors included in the transcriptional 
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complex regulates transcriptional activity of target genes (Macias-Silva et al. 1996, 
Zhang et al. 1996, Nakao et al. 1997).  
Extracellular activation of TGFB results from conformational changes in the 
latent complex or dissociation of TGFB from LAP (Annes et al. 2003, Jenkins 2008, 
Wipff & Hinz 2008).  In addition to conferring latency to TGFB, the LAPs that associate 
with TGFBs 1 and 3 contain  Arg-Gly-Asp (RGD) sequences that are recognized and 
bound by specific integrins (Ruoslahti 1996).  Integrins are a family of transmembrane 
glycoprotein receptors that form non-covalent alpha and beta heterodimers, bind to 
multiple ECM proteins, aggregate, and form focal adhesions to stabilize cell attachments 
and serve as signaling centers (Hynes 1992, Wozniak et al. 2004, Bershadsky et al. 
2006a, Zaidel-Bar et al. 2007).  LAP via its RGD sequence can bind to integrin 
heterodimers on cell surfaces (Munger et al. 1998, Munger et al. 1999, Mu et al. 2002, 
Ludbrook et al. 2003), and these interactions, along with TGFB and TGFBR 
interactions, may function in supporting events of the peri-implantation period.   
  The consequences of altering or interfering with receptor-ligand interactions 
involving TGFB, LAP, and integrins within the uterus during porcine pregnancy have 
not yet been determined.  We hypothesize that altering such interactions will affect 
conceptus development and attachment.  Conduct of such investigations would require a 
specialized means for in vivo intrauterine infusion of exogenous proteins which is also 
compatible with maintenance of pregnancy.  Therefore, the first objective of this study 
was to develop a system using interiorized catheters which would facilitate repeated 
delivery of agents, such as exogenous proteins at physiological concentrations, directly 
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into the uterus of pregnant gilts and require minimal post surgery manipulation and 
restraint.    
The second objective of this study was to use the technique developed in study 1 
to infuse exogenous LAP directly into the uterus of pregnant gilts to alter receptor-ligand 
interactions of TGFB and TGFBRs, LAP and integrins.  The use of this novel delivery 
system to infuse LAP containing its native RGD site (LAP-RGD) and a recombinant 
mutant of LAP (LAP-RGE) into the uterine lumen of pregnant gilts will aid in our 
understanding of TGFB and LAP-integrin mediated effects on conceptus development 
and attachment.  LAP decreases in vitro TGFB activity by recombining with active 
TGFBs, rendering them latent, and thus inhibiting TGFB from binding to TGFBRs.  
Further in vitro evidence supports that LAP-RGD, but not LAP-RGE, can bind to 
integrin receptors and support cell adhesion (Jaeger et al. 2005).  Exogenous LAP-RGD 
infused into the uterine lumen of pregnant gilts beginning on day 9 of pregnancy is 
expected to disrupt the balance of active TGFB and alter normal integrin signaling 
during the peri-implantation period, whereas exogenous LAP-RGE infusions will disrupt 
TGFB activity without altering integrin-ligand interactions at the conceptus-maternal 
interface.   
We hypothesize that intrauterine infusion of LAP –RGD during the peri-
implantation period will decrease downstream signaling of TGFB at the conceptus-
maternal interface, while also increasing LAP-integrin interactions, and that the net 
effect will be enhanced conceptus survival and attachment early in the peri-implantation 
phase, but possibly abnormal placentation later in pregnancy.  In contrast, infusion of 
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LAP-RGE will disrupt TGFB signals, but because of the RGD to RGE mutation, will not 
alter integrin signaling and thus the net result will be decreased conceptus survival and 
abnormal development.  This design will aid in distinguishing between TGFB- and 
integrin-mediated effects on conceptus development and attachment. 
 
Materials and Methods 
Animals and Tissue Collection 
 All experimental and surgical procedures complied with the Guide for Care and 
Use of Laboratory Animals and approved by the Texas A&M University Laboratory 
Animal Care and Use Committee.  Gilts were observed daily for estrus (day 0) and 
mated with boars at 12 and 24 h after the onset of estrus. 
 Study One.  A primary experimental need of our laboratory is to be able to 
deliver low concentrations of proteins to the pregnant uterus during the peri-implantation 
period without adverse effects on the endometrial mucosa, conceptus development, or 
conceptus attachment.  Thus, three gilts underwent bilateral catheterization of uterine 
horns and received infusions of 0.1% PSA from days 9 to 13 of pregnancy.  Because 
some studies may require maintenance of pregnancy beyond the pre-implantation period, 
additional three gilts were used to determine whether catheterization and infusion of 
0.1% PSA would be compatible with the maintenance of pregnancy for the duration of 
the period of conceptus attachment, extending through day 24 of pregnancy.  All gilts 
underwent an initial surgery on day 9 of pregnancy and were ovariohysterectomized on 
either day 13 or 24 of pregnancy.    
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 Anesthesia was induced in gilts on day 9 of pregnancy by intramuscular injection 
of a tiletamine hydrochloride and zolazepam hydrochloride (6.6 mg/kg), and was 
maintained with isoflurane (2-4% in oxygen).  Sterile ALZET® osmotic pumps (Durect 
Corp., Cupertino, CA), previously prepared as per manufacturer’s instructions, were 
installed into each uterine horn.  To install the pumps, Metzenbaum scissors were used 
to transect the uterine tube 3-5 cm distal to the uterotubal junction.  The polyethylene 
catheter (1.2 mm outside diameter) was inserted into the transected end of the uterine 
tube and threaded toward the uterine horn until 1-2 cm of the catheter resided in the 
uterine horn.  In some cases, the mesosalpinx was cut to relieve tortuosity of the uterine 
tube and facilitate passage of the catheter.  Two encircling ligatures of 2-0 polygalactin 
910 were placed around the uterine tube containing the polyethylene catheter 
approximately 2-3 mm apart and beginning 2-3 mm from the transected end of the 
uterine tube.  The tails of the suture were wrapped around the tubing in a crossing 
fashion that allowed the suture to tighten around the tube if the tube began to slide out of 
the uterine tube.  The junction of the uterine tube and polyethylene catheter was dried 
with a gauze sponge and 1-2 drops of sterile cyanoacrylate glue were applied to the 
uterine tube, catheter, and suture. After the catheter was secured in the uterine tube, the 
pump was slipped into the ovarian bursa and the mesovarium was sutured closed, using 
2-0 polygalactin 910.  Two additional encircling sutures were placed through the 
mesovarium, around the pump, to ensure that the pump remained in the bursa adjacent to 
the ovary (Figure 4.1).  Ovariohysterectomies were performed on days 13 and 24 of 
pregnant gilts.  Immediately after removal, reproductive tissues were visually assessed to
 Figure 4.1.  Surgical Implantation of Osmotic Pumps. A) The uterine tube was transected (arrow) and the polyethylene 
catheter inserted and passed toward and then into the uterine horn.  The mesosalpinx (arrowhead) was often transected to help 
relieve tortuosity of the uterine tube and ease passage of the catheter.  B)   Encircling ligatures were used to secure the 
polyethylene catheter within the uterine tube (arrow) and 1-2 drops of sterile cyanoacrylate glue were applied to the uterine 
tube, catheter and suture.   The pump was slipped into the ovarian bursa and two encircling sutures (arrowhead) were placed 
through the mesovarium, around the pump. 
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assure placement and patency of catheters and document the conditions of the ovaries 
and any gross abnormalities of the reproductive tract.  In addition, any remaining fluid 
was aspirated from the removed pumps and measured to assure that pumps had delivered 
the expected volume of fluid over the experimental period.  On day 13 of pregnancy, 50 
mLs of 10 mM Tris was used to flush conceptuses from each horn separately.  On day 
24 of pregnancy, uterine horns were not flushed but rather opened longitudinally along 
the anti-mesometrial border.  The presence and gross normality of fetuses was visually 
assessed.  Day 13 conceptuses and full thickness uterine tissue samples from days 13 and 
24 of pregnancy were fixed in 4% paraformaldehyde (4% PAF) prepared in phosphate 
buffered saline (PBS), pH 7.2.  Routine processing of uterine and conceptus tissues into 
paraffin followed.  Sections were processed and stained with hematoxylin and eosin 
(H&E), and evaluated by a board-certified pathologist.   
 Study Two.  To evaluate the effect of exogenous recombinant LAP-RGD or LAP-
RGE at the conceptus-maternal interface during the peri-implantation period, gilts 
received infusions in both uterine horns of either LAP-RGD, LAP-RGE, or PSA control 
(9.6 μg LAP-RGD or LAP-RGE per horn per day delivered in PSA vehicle for a total 
protein concentration of 1 mg/ml; n=5 gilts/treatment group) beginning on day 9 of 
pregnancy.  Surgical implantation of two indwelling osmotic pumps was performed on 
day 9 of pregnancy, as described in study 1.  Pumps delivered either LAP-RGD, LAP-
RGE, or PSA into each uterine horn at a rate of 10 ul/hour.  On day 13 of pregnancy, 
ovariohysterectomies were performed and assessment of placement and patency of 
catheters was noted, as described in study 1.  Conceptuses from each uterine horn were 
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flushed with 10 mM Tris HCl on day 9 of pregnancy, and both uterine and conceptus 
tissues were preserved as described in study 1.   
 Treatments that resulted in grossly normal conceptus development and 
maintenance of pregnancy on day 13 were used for an additional experiment using 
another group of gilts, beginning on day 9 of pregnancy and concluding at the 
completion of implantation, on day 24 of pregnancy.  Day 9 pregnant gilts underwent 
surgical implantation of two indwelling osmotic pumps as described above; pumps 
delivered either LAP-RGE or PSA control (9.6 μg LAP-RGE per horn per day delivered 
in PSA vehicle for a total protein concentration of 1 mg/ml; n=5 gilts/treatment group) 
for approximately 6.5 days, until the 2 ml volume within the pump was expended.  At 
ovariohysterectomy on day 24 of pregnancy, uterine horns were opened along the anti-
mesometrial border, and placental and fetal parameters including allantois length (cm), 
allantoic fluid volume (mL), fetal length (crown to rump, cm), fetal weights (g), and 
number of fetuses per litter were recorded.  Placental attachment sites and fetuses were 
preserved in 4% PAF as described, and placental attachment sites were routinely 
processed, embedded in paraffin, sectioned, stained with H&E, and evaluated 
histopathologically as described above.      
         
Immunohistochemistry 
 Rabbit anti-phosphorylated SMAD2/3 (p-SMAD2/3) from Santa Cruz (Santa 
Cruz, CA) was used for immunohistochemical staining.  Uterine and conceptus paraffin 
embedded tissues were sectioned (5 µM) and mounted on Superfrost plus slides.  Tissues 
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were then deparaffinized with xylene and rehydrated through a graded series of alcohol.  
Endogenous peroxidase was blocked with 0.3% H2O2 in dH2O.  Sections were subjected 
to antigen retrieval with citrate buffer (pH 6.2) at 80°C for 45 min.  Sections were 
blocked with 10% normal goat serum at 25°C for 20 min, and incubated overnight at 
4°C with primary antibody p-SMAD 2/3 (0.4 μg/ml) or control Rabbit IgG (0.4 μg/ml) 
in 2% bovine serum albumin (BSA) in PBS (PBSA).  Sections were rinsed with PBSA 
and PBSA containing 1% Triton and incubated with biotinylated-conjugated secondary 
antibody diluted in PBSA containing 5% normal goat serum for 1 h at 25ºC.  Sections 
were then rinsed as described, incubated in Vectastain ABC (Vector Laboratories, 
Burlingame, CA) for 30 min at room temperature, and then rinsed again with PBS and 
0.5 M Tris-HCl.  Immunoreactions were detected with peroxidase solution (DAB/H2O2) 
and stopped by submerging in H2O at 1.5 min after application of peroxidase solution.  
Sections were counterstained with Shandon Eosin-y aqueous (Thermo Scientific, 
Waltham, MA), rinsed with distilled water, dehydrated with the reverse series of graded 
alcohol, and covered slipped with Clarion Mounting Medium (Biomeda Corp, Foster 
City, CA).  Sections were evaluated by two independent investigators who were blinded 
to sample identity and treatment.  Intensity of p-SMAD2/3 immunostaining for 
trophectoderm, uterine LE, and glandular (GE) was graded as; (–) no immunostaining, 
(+) weak and/or intermittent immunostaining, (++) moderate immunostaining, or (+++) 
strong immunostaining. 
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Statistical Analysis 
 Quantitative data from day 24 infused gilts in study 2 were subjected to least-
squares analysis of variance (ANOVA) using the General Linear Models procedures of 
the Statistical Analysis System (SAS Institute, Cary, NC).  Tests of significance were 
performed using the appropriate error terms according to the expectation of the means 
squares for error, and P < 0.05 was considered statistically significant.  
 
Photomicrography 
 Digital photomicrographs of immunohistochemistry and H&E stained sections 
were evaluated using an Axioplan 2 microscope (Carl Zeiss, Thornwood, NY) interfaced 
with an Axioplan HR digital camera and Axiovision 4.3 software.  Photographic 
templates were assembled using Adobe Photoshop (version 6.0, Adobe Systems Inc., 
San Jose, CA). 
 
Results 
Effects of Surgical Implantation of Osmotic Pumps and Infusion of PSA on Endometrial 
Morphology, Conceptus Development, and Conceptus Attachment (Study 1) 
 At hysterectomy, uteri from all three gilts exhibited normal muscular tone and 
visible exterior striations as is commonly observed at this stage of pregnancy, and 
catheters and pumps remained in place (Figure 4.2).  In gilts receiving PSA treatment 
until day 13 of pregnancy, conceptuses were recovered from both uterine horns.  Some 
variability in developmental stage was observed between and within the recovered
 100
 
 
 
 
 
Figure 4.2. Exteriorized Uterus and Ovaries Just Prior to Ovariohysterectomy on 
Day 13 of Gestation.  The muscular striations and uterine tone are usual for this day of 
gestation during which conceptuses secrete estrogens. Corpora lutea (arrowheads) are 
present on the ovaries.  Pumps are enclosed within the ovarian bursa (arrows). Fluid 
accumulation within the bursa, as seen here, was observed occasionally.
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litters, however, all conceptuses were in elongated, filamentous forms (Figure 4.3a).  
The mucosa of the endometrium, after opening the horns longitudinally, appeared 
grossly normal in all three gilts.  In gilts receiving PSA treatments until day 24 of 
pregnancy, implantation sites were maintained, and development of fetuses appeared to 
be grossly normal (Figure 4.4a). 
 No significant histopathological abnormalities were noted in H&E stained 
sections of day 13 endometrial mucosae or conceptus tissue or day 24 implantation sites 
(Figure 4.3b and 4.3c, Figure 4.4b).  All endometrial sections were characterized by 
mild submucosal edema with occasional dilated lymphatics, mild margination of 
neutrophils within submucosal veins, and rare submucosal eosinophils.  Occasionally, a 
few necrotic or apoptotic cells were observed with day 13 conceptus trophectoderm.  
   
Intrauterine Infusion of Recombinant LAP-RGD Reduced Conceptus Elongation (Study 
2)  
 Fifteen gilts underwent bilateral surgical implantation of osmotic pumps filled 
with LAP-RGD, LAP-RGE, or PSA control beginning on day 9 of pregnancy.  On day 
13 of pregnancy, infused gilts were ovariohysterectomized and morphology of their 
conceptuses were assessed.  In the LAP-RGD infused gilts, reduction in conceptus 
elongation in both horns of 4 out 5 litters was grossly visible (Figure 4.5).  In litter A, 
spherical and filamentous conceptuses with bulbous ends were present, and two 
spherical conceptuses had sizes 0.5 cm and 0.65 cm.  In litter B, spherical and 
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Figure 4.3. Normal Filamentous Conceptuses Flushed from Uterine Horns of PSA 
Infused Pregnant Gilts on Day 13 of Pregnancy.  A) Conceptuses flushed from the 
uterus of the PSA infused horns exhibited a range of filamentous morphology consistent 
with this stage of gestation.  Bar = 1 cm. B) Filamentous conceptus showing normal 
morphologic development for this stage of gestation: embryonic ectoderm, arrow; 
trophectoderm, arrowhead. Bar = 50 microns. C) Normal uterine tissue from PSA 
infused horns, day 13 of pregnancy, H&E stain. Endometrial mucosae were 
characterized by normal luminal epithelium (arrow) and slightly edematous underlying 
stromal tissue. 
 
 103
 
 Figure 4.4.  Normal Fetus and Placenta from PSA Infused Horn, Day 24 Gestation.  A.  Morphologically normal fetus 
(arrow) and placenta present in uterine horn infused with PSA beginning on day 9 gestation. Bar = 1cm.  B.  The chorion of the 
conceptus is interdigitating with the underlying maternal endometrial epithelium (arrowhead); placentation appears to be 
proceeding in a normal manner.  H&E stain; bar = 50 microns.
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 Figure 4.5. Morphology of Day 13 Conceptuses Flushed from Uterine Horns of LAP-RGD, LAP-RGE, and PSA Infused 
Pregnant Gilts. Conceptuses were flushed from right and left horns of LAP-RGD treated pregnant gilts (n = 5; top two rows; 
right horn, top row; left horn, second row).  Litters A-E show spherical and filamentous conceptuses.  Note litter E exhibited 
no elongation.  Filamentous conceptuses were seen in LAP-RGE (third and fourth rows) and PSA (fifth and sixth rows) 
treatment groups.  Bar = 1 cm. 
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Figure 4.5. Continued
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Figure 4.5. Continued
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filamentous conceptuses were present, and 5 spherical conceptuses had sizes 0.15 cm, 
0.5 cm, 0.9 cm, 1.0 cm, and 1.0 cm.  In litter C, conceptuses appeared to elongate; 
however, some filamentous conceptuses appeared to have lost their normal structure and 
presented as sheets of trophoblast.  In litter D, spherical and filamentous conceptuses 
with bulbous ends were present, and three spherical conceptuses had sizes 0.6 cm, 0.75 
cm, and 0.8 cm.  In litter E, all conceptuses failed to elongate; conceptuses were 
characterized as 5 spherical and 1 tubular and ranged in sizes 0.3 cm, 0.4 cm, 0.5 cm, 0.7 
cm, and 0.9 cm; and 1.5 cm. 
 In LAP-RGE and PSA infused gilts, overall morphology of conceptuses in both 
treatment group were grossly normal (Figure 4.5).  Nearly all conceptuses from all gilts 
in LAP-RGE and PSA treatment groups were filamentous, and few filamentous 
conceptuses contained bulbous ends.  Only 1 spherical conceptus was reported for each 
LAP-RGE and PSA infused litters, and their sizes were 0.8 cm and 1.0 cm, respectively.  
 
p-SMAD 2/3 Immunohistochemistry (Study 2) 
 SMAD proteins 2 and 3 are phosphorylated in response to TGFB signaling 
through TGFBRs and are subsequently translocated to nuclei.  Therefore, 
immunohistochemical analysis of nuclear p-SMAD2/3 was performed on day 13 
conceptus and endometrial tissues of each treatment group (LAP-RGD, LAP-RGE, or 
PSA) as an assessment of TGFB activity within uterine and conceptus tissues.  In all 
treatment groups, p-SMAD2/3 was detected in nuclei of the conceptus trophectoderm, 
endometrial LE, endometrial GE, fibroblast cells, and endothelial cells (Figure 4.6).  
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Immunostaining for p-SMAD2/3 in the LAP-RGE treatment group appeared less intense 
in endometrial LE compared to immunostaining in LE of LAP-RGD and PSA treatment 
groups and was graded a lower score in blind-ended evaluations (Table 4.1).   
 
Intrauterine Infusions of Recombinant LAP-RGE Affects Placental and Fetal 
Development (Study 2) 
 Conceptus development was impaired by day 13 of pregnancy when LAP-RGD 
was infused into the uterus; however, conceptuses from LAP-RGE treatment groups 
achieved elongation, and no disruption of pregnancy was apparent.  Therefore, 
additional studies were employed to determine if infusing LAP-RGE resulted in long-
term effects on conceptus attachment and/or fetal and placental development.  Pregnant 
gilts were infused with LAP-RGE or PSA control beginning on day 9 of pregnancy and 
hysterectomized on day 24.  These infusions, which spanned from day 9 to 
approximately day 15.5 of pregnancy, were designed to determine effects on 
implantation and conceptus development that would result from LAP-induced inhibition 
of TGFB activity that was not accompanied by concurrent alteration of integrin activity 
from the native RGD site present in LAP.  
 H&E sections of placental attachment sites in LAP-RGE and PSA groups 
indicated that infusions of LAP-RGE resulted in no detectable histopathological 
abnormalities in attachment (Figure 4.7).  Fetal weight (g), fetal length (cm), allantois 
length (cm), allantoic fluid volume (mL), and number of fetuses for LAP-RGE and PSA 
 Figure 4.6.   Immunohistochemical Localization of p-SMAD2/3 protein in paraffin-embedded uterine cross-sections from 
day 13 PSA (first column), LAP-RGD (second column), and LAP-RGE (third column) infused pregnant pig endometrium and 
conceptuses.  The brown color indicates positive immunostaining for p-SMAD2/3.  All sections were counterstained with 
Shandon Eosin-y aqueous.  Sections stained with nonimmune rabbit IgG (fourth column) serve as negative controls.  LE, 
luminal epithelium; GE, glandular epithelium; Tr, trophectoderm.  Width of fields are 230µm. 
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Table 4.1. p-SMAD 2/3 Porcine Endometrial and Conceptus Immunostaining for 
LAP-RGD, LAP-RGE, or PSA Infused Gilts (Day 13 of Pregnancy).  p-SMAD 2/3 
immunostaining was evaluated visually within cell population, (-) no immunostaining, 
(+) weak, (++) moderate, or (+++) strong. 
 
 
 
 
 
 
IHC p-SMAD2/3 Detection: Comparison 
Across Treatment Groups 
 LE GE Tr 
PSA +++ +++ +++ 
LAP-RGD +++ ++ +++ 
LAP-RGE ++ +++ +++ 
 
   
 
 
Figure 4.7. Conceptus Attachment Site From PSA and LAP-RGE Infused Gilts, Day 24 Gestation.  PSA and LAP-RGE 
exhibited normal conceptus attachment and placentation appears to be proceeding in a normal manner. LE, luminal epithelium; 
Tr, trophectoderm. H&E stain.  
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treatment groups were recorded at ovariohysterectomy on day 24 of pregnancy.  The 
least square means and standard errors for LAP-RGE treatment group were 0.47 ± 0.04 g 
fetal weight, 1.55 ± 0.08 cm fetal length, 11.85 ± 0.97 cm allantois length, 54.37 ± 5.38 
mL allantoic fluid volume, and 8.60 ± 0.71 number of fetuses per litter.  Means and 
standard deviations for PSA control group were 0.29 ± 0.04 g fetal weight, 1.36 ± 0.08 
cm fetal length, 8.17 ± 1.03 cm allantois length, 24.16 ± 4.89 mL allantoic fluid volume, 
and 8.20 ± 0.71 number of fetuses (Table 4.2).  Compared to PSA infusions, LAP-RGE 
infusions resulted in larger fetal mass (P < 0.05), allantois length (P < 0.05), and 
allantoic fluid volume (P < 0.01; Figure 4.8).   
   
Discussion 
 Results of study 1 indicate that substances can be infused in a continuous, 
controlled manner to the intrauterine lumen of pregnant gilts and, further, that such 
infusion is compatible with maintenance of pregnancy.  The surgical techniques 
described in this report were successful in allowing continual infusions into the uterine 
lumen over the entire time periods defined.  Compared to alternative methods that use 
exteriorized catheters (Harney & Bazer 1990, Sample et al. 2000, Sample et al. 2004, 
Jana et al. 2007), the use of surgically implanted, commercially available osmotic pumps 
permits minimal manipulations and disruptions to the animal during the period of 
treatment, continual infusion of substances rather than multiple bolus treatments, and 
decreased risk of infection from environmental sources.  The process of infusion did not 
result in any gross or histopathologically significant alterations of the endometrium and 
 
 Table 4.2.  Mean ± SEM for Fetal Weight, Fetal Length, Allantois Length, Allantoic Fluid Volume, and Number of 
Fetuses.  Tests of significance were performed using the appropriate error terms according to the expectation of the means 
squares for error, and P < 0.05 was considered statistically significant. NS, not significant (P > 0.05). 
 
 
 
Treatment 
Fetal Weight 
(g) 
Fetal Length 
(cm) 
Allantois Length 
(cm) 
Allantoic fluid Volume 
(ml) 
Number of 
Fetuses 
LAP-RGE 0.47 ± 0.04 1.55 ± 0.08 11.85 ± 0.97 54.37 ± 5.38 8.6 ± 0.71 
PSA 0.29 ± 0.04 1.36 ± 0.08 8.17 ± 1.03 24.16 ± 4.89 8.2 ± 0.71 
 P<.005 NS P<.05 P<.01 NS 
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Figure 4.8.  Fetal Weight, Fetal Length, Allantois Length, Allantoic Fluid Volume, 
and Number of Fetuses from Day 24 LAP-RGE and PSA Infused Gilts in Study 2.  
Mean ± SEM for fetal weight, fetal length, allantois length, allantoic fluid volume, and 
number of fetuses are represented in bar graphs. Fetal weights (P < 0.05), allantois 
length (P < 0.05), and allantoic fluid volume (P < 0.01) were larger in LAP-RGE 
treatment group compared to PSA treatment group.  
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conceptus tissues or conceptus attachment sites at day 24 of pregnancy.  Mild 
submucosal edema, dilated lymphatics, mild margination of neutrophils, and submucosal 
eosinophils were observed in the endometrium from all uteri; all changes were consistent 
with procedural effects of surgery resulting from clamping, suturing, and/or handling 
and are not considered to be pathologically significant.  Thus, it appears that the infusion 
technique reported in study 1 would be broadly applicable to a wide range of studies 
focused on endometrial function during pregnancy.  Finally, results of this study clearly 
demonstrate that uterine infusion is compatible with maintenance of pregnancy through 
the peri-implantation period.  
 Results of study 2 demonstrate that intrauterine infusions of LAP-RGD, but not 
LAP-RGE or PSA, beginning on day 9 of pregnancy in gilts resulted in a reduction of 
conceptus elongation.  Further, intrauterine infusions of LAP-RGE through the peri-
implantation period grossly resulted in normal implantation and placental and fetal 
development.  Further assessment of fetal and placental parameters indicated that 
infusing with LAP-RGE results in larger fetal weight, allantois length, and allantoic fluid 
volume compared to infusing with PSA.     
 
Alterations in Integrin-Ligand Interactions Reduces Conceptus Elongation 
 Conceptus loss can reach 18% during pre-implantation, and during this time, 
conceptus extraembryonic tissues elongate from a 5 mm sphere to a 150 mm filamentous 
form at a rate of 30-40 mm/hr between days 10 and 12 of pregnancy (Geisert et al. 
 
 123
1982b, Bennett & Leymaster 1989).  The elongated conceptus provides increased 
surface area for exchange of nutrients between the conceptus and uterus and is essential 
for successful implantation.  Investigating which factors mediate conceptus elongation is 
complicated by the failure of conceptuses to elongate in vitro (Stroband & Van der 
Lende 1990).    
 We are the first to demonstrate in vivo inhibition of conceptus elongation via 
intrauterine infusions during early pregnancy in pigs.  Infusions of LAP-RGD inhibited 
conceptus elongation, whereas similar infusions of LAP-RGE had no visible effect on 
conceptus elongation.  LAP-RGD, but not LAP-RGE, supports binding to integrins, and 
intrauterine infusions of LAP-RGE did not affect conceptus elongation, implicating 
integrin-mediated effects in inhibiting conceptus elongation.  In studies involving mice, 
intrauterine injections of RGD containing peptides and neutralizing monoclonal 
antibodies against integrin subunits resulted in the reduction of implantation (Illera et al. 
2000).  In addition, phenotypes in mice with ITGA4, ITGA5, ITGAV, and ITGB1 null 
mutations resulted in failure of chorioallantois fusion, placental defects, and embryonic 
deaths (Dickson et al. 1995, Fassler & Meyer 1995, Stephens et al. 1995, Hynes & 
Bader 1997, Bader et al. 1998, Chung et al. 2000).  In recent studies, intracellular 
signaling pathways involving TGFB and integrins were identified during conceptus 
elongation suggesting mechanisms for growth factor signaling and cytoskeletal 
rearrangement/cell motility during conceptus elongation (Blomberg et al. 2008).  These 
studies, along with our current study, provide evidence that integrins are critical during 
the peri-implantation period.   
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 Integrins via receptor-ligand induced formation of multi-protein intracellular 
focal adhesions can serve to provide links to the actin cytoskeleton and activate multiple 
downstream signaling pathways resulting in reorganization of the cytoskeleton and 
regulating cellular behaviors such as cell proliferation, differentiation, and migration 
(Gilcrease 2007).  A potential mechanism for LAP-RGD inhibition of conceptus 
elongation is that infused LAP-RGD binds one or more integrins inappropriately, thus 
preventing other integrin-ligand interactions or, alternatively, inappropriately stimulates 
ITGAV-containing heterodimers, therefore, causing interruptions in linking the actin 
cytoskeleton and intracellular signaling cascades that may critical for conceptus 
elongation.                  
  In the LAP-RGD treatment group, some conceptuses achieved elongation.  
Osmotic pumps installed on day 9 of pregnancy delivered infusate at a rate of 10 μl/hr.  
A slow continuous infusion of protein is optimal for maintaining physiological 
concentrations; however, the infusate may not reach the entire length of the uterine horn 
in time to completely disrupt receptor-ligand interactions.  As a result, the conceptuses 
that achieved morphological elongation may not have been exposed to exogenous LAP-
RGD within a critical period which, based on morphology of conceptuses, appears to 
encompass 10 of pregnancy.       
 
TGFB is Functional in LAP-RGD and LAP-RGE Treatment Groups 
  Infusing LAP-RGD and LAP-RGE is expected to disrupt the balance of active 
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TGFB at the conceptus-maternal interface.  Detection of p-SMAD2/3 in day 13 
conceptus and endometrial tissues of LAP-RGD, LAP-RGE, and PSA treatment groups 
provides evidence that TGFB signals through TGFBRs and activates downstream 
SMAD signaling in conceptus and endometrial tissues during LAP intrauterine 
infusions.  LAP-RGD and LAP-RGE infusions may initially recombine with active 
TGFB, rendering it latent; however, several mechanisms involving integrins and 
proteases can activate TGFB.  
 Integrins have been implicated in activation of TGFB in vivo (Sato & Rifkin 
1989, Shull et al. 1992, Taipale et al. 1992, Huang et al. 1996, Bader et al. 1998, Zhu et 
al. 2002).  Integrins bind to latent TGFB via the RGD sequences in LAP and activate 
TGFB via traction forces or with the aid of proteases (Munger et al. 1998, Munger et al. 
1999, Annes et al. 2002, Mu et al. 2002, Asano et al. 2005a, Asano et al. 2005b, Wipff 
& Hinz 2008).  ITGAV- containing heterodimers are present in trophectoderm and 
uterine LE during porcine implantation (Bowen et al. 1996, Burghardt et al. 2002), and 
in addition to integrins, proteases such as plasmin and matrix metalloproteinases 
(MMPs) have been identified during porcine pregnancy.  Proteases involved in TGFB 
activation include, but not limited to, plasmin and MMPs, which activate TGFB mostly 
by proteolytic cleavage of LAP (Lyons et al. 1990, Yu & Stamenkovic 2000, Jenkins 
2008).  MMP2 is present during porcine pregnancy with increasing detectable amounts 
between days 10 to 14 of pregnancy (Foxcroft et al. 2000, Kayser et al. 2006).  
Plasminogen, plasmin’s proprotein, was also found within the uterine lumen, and its 
activator urokinase plasminogen activator (uPA) is expressed in porcine blastocysts, 
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suggesting potential for temporal production of plasmin (Fazleabas et al. 1983).  In 
LAP-RGD treated gilts, TGFB scavenged by LAP-RGD can presumably be activated via 
integrins and proteases such as MMP2 and plasmin.  However, in LAP-RGE treated 
gilts, because LAP-RGE does not support binding to integrins, it is reasonable to assume 
that TGFB scavenged by LAP-RGE may be activated only by proteases and is not 
available for integrin-mediated activation.    
 
 LAP-RGE Affects Placental Size  
  Porcine implantation is non invasive; therefore, there is a need for a large 
surface area between placental and endometrial tissue for exchange of nutrients to 
support the growing fetus.  Placental efficiency is measured by fetal weight-to-placental 
weight ratio, and large placental sizes are implicated as a limiting factor to litter size 
(Wilson et al. 1999, Wilson & Ford 2001).  Novel experiments by Wilson and Ford, 
have demonstrated that administration of estradiol-17B around the time of conceptus 
elongation results in increased placental size at term.  Increases in estradiol-17B may 
affect endometrial secretions of growth factors, which may ultimately affect placental 
size (Wilson & Ford 2000).  In support of this, our studies have demonstrated that 
infusing exogenous LAP-RGE during the time of conceptus elongation results in 
increased fetal weight, allantois length, and allantoic fluid volume; however, litter size 
and fetal length were not affected.  In our model, infusing LAP-RGE appeared to result 
in a decrease in SMAD signaling in the uterine LE.  The apparent decrease in SMAD 
signaling in epithelial cells may affect critical TGFB-regulated processes such as cell 
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growth arrest, proliferation, apoptosis, migration, and differentiation during porcine 
pregnancy.  TGFB participates in regulating cellular growth, apoptosis, and 
differentiation in many cell types including epithelial, endothelial, and mesenchymal 
cells (Rahimi & Leof 2007).  TGFB can induce cell cycle arrest by up-regulating cell 
cycle inhibitors such cyclin-dependent kinase (CDK) inhibitors via SMAD signaling 
pathways.  In addition, TGFB signaling via SMADs can also up-regulate pro-apoptotic 
proteins, down-regulate pro-survival proteins, and induce epithelial-mesenchymal 
transition (Rahimi & Leof 2007).   We hypothesize that alterations in TGFB induced 
SMAD signaling regulating cellular behavior such as growth, proliferation, migration, 
and apoptosis during the porcine peri-implantation period result in larger placental and 
fetal parameters, particularly allantois lengths and fetal weight as seen in day 24 LAP-
RGE infused gilts.                         
 In summary, we have developed a successful technique for immobilizing osmotic 
pumps in the porcine reproductive tract and delivering substances into the luminal cavity 
of the uterus.  This methodology should prove useful for studies of uterine physiology 
and pathophysiology during early conceptus development that are relevant to pigs and 
other mammals.  By use of these novel techniques, we demonstrate that infusing LAP-
RGD beginning on day 9 of porcine pregnancy reduces conceptus elongation suggesting 
that appropriate integrin-ligand interactions are necessary for successful conceptus 
elongation during porcine pregnancy.  In addition, infusing LAP-RGE beginning on day 
9 of porcine pregnancy results in larger fetal weight, allantoic length, and allantoic fluid 
volume compared to infusing with PSA.  The phenotype seen at day 24 of pregnancy 
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may be a result of altering TGFB induced SMAD signaling in epithelial cells during the 
critical time of conceptus elongation and implantation ultimately affecting fetal weight, 
allantoic length, and allantoic volume.  Although the precise mechanisms are not known 
at this time, current results implicate TGFB and integrins as contributing factors in the 
regulation of conceptus elongation and placental and fetal size. 
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CHAPTER V 
INVESTIGATIONS INTO MECHANISMS UNDERLYING  
LAP-RGD INDUCED INHIBITION OF CONCEPTUS ELONGATION 
 
Introduction 
Porcine implantation is superficial and non-invasive, and prior to their attachment 
to the uterine luminal epithelia (LE), conceptuses undergo elongation.  Porcine conceptus 
elongation occurs between days 11 and 12 of pregnancy, and conceptuses elongate from 
spherical to filamentous forms. Spherical day 10 porcine blastocysts (2-6 mm) undergo 
morphological transition to larger spheres (10 to 15 mm) to tubular (15 mm by 50 mm) 
and then to filamentous (l mm by 100-200 mm) forms by day 12 of pregnancy (Geisert et 
al. 1982b).  The elongated conceptus provides increased surface area for exchange of 
nutrients between the conceptus and uterus and is essential for successful implantation 
(Stroband & Van der Lende 1990).   
Molecules such as transforming growth factor betas (TGFBs) and integrins are 
among the various signaling molecules that have been reported to be present in uterine 
and placental tissues prior to and during implantation in pigs (Bowen et al. 1996, Gupta 
et al. 1998a, Burghardt et al. 2002).  TGFB is a homodimer containing non-covalent 
associations with its prepropeptide homodimer, latency associated peptide (LAP) 
(Lawrence et al. 1984, Gentry et al. 1988).   Like many ECM proteins, LAP1 and 3 
monomers, which correspond to their respective TGFB1 and 3 isoforms, contain an 
arginine-glycine-aspartate (RGD) site.  Previous studies have demonstrated that LAP 
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binds to integrin heterodimers via this RGD sequence (Munger et al. 1998, Mu et al. 
2002, Ludbrook et al. 2003).  Interactions between LAP and integrins, along with TGFB 
and TGFB receptors (TGFBRs) and the signals they transmit, may be important in 
supporting events of conceptus elongation and attachment.  Mechanisms supporting 
conceptus elongation are largely unknown; however, our studies indicate that infusion of 
exogenous LAP with a native RGD sequence into the uterine lumen of pregnant gilts, 
beginning day 9 of pregnancy, reduced conceptus elongation.  Conceptus elongation was 
not affected in gilts similarly infused with exogenous LAP which contained a mutated 
sequence (RGE).  In vitro, LAP decreases TGFB activity by recombining with active 
TGFBs, rendering them latent, and thus inhibiting TGFB from binding to TGFBRs; 
therefore, infusing exogenous LAP into the uterine lumen of pregnant gilts was expected 
to alter receptor-ligand interactions of TGFB and TGFBRs.  Further, infusions of LAP-
RGD, but not LAP-RGE, are also expected to alter normal integrin signaling. 
In an attempt to investigate mechanisms of action that resulted in reduction of 
conceptus elongation in LAP-RGD infused gilts, a wide range of experiments was 
employed in this study.  Based on our results, we hypothesize that infused LAP-RGD 
bound to integrin ligands via the RGD sequence, preventing other ligands from binding to 
integrins, and therefore, impeding integrin signaling critical to mediating initiation of 
conceptus elongation and successful attachment.  It is important to note that, at the time 
some of the experiments were initiated, we had conducted only LAP-RGD infusions and 
not the LAP-RGE infusions, so the possibility that the observed inhibition of conceptus 
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elongation could be attributed to altered TGFB levels was still a viable alternative 
hypothesis.   
    
Materials and Methods 
Animals  
 Experimental procedures were approved by Texas A&M University’s Animal 
Care and Use Committee (AUP # 2007-154).  Crossbred gilts were checked daily for 
estrus, and bred approximately 12 and 24 hours after their second detected estrus.  
Anesthesia was induced in gilts, on day 9 of pregnancy, by intramuscular injection of a 
tiletamine hydrochloride and zolazepam hydrochloride (6.6mg/kg) and was maintained 
with isoflurane (2-4% in oxygen).  Sterile ALZET® osmotic pumps (Durect Corp., 
Cupertino, CA), previously prepared as per manufacturer’s instructions, were installed 
into each uterine horn.  The polyethylene catheter (1.2 mm outside diameter) was inserted 
into the transected end of the uterine tube and threaded toward the uterine horn until 1-2 
cm of the catheter resided in the uterine horn. 
Sterile pumps contained either exogenous recombinant LAP-RGD, LAP-RGE, or 
PSA control (9.6 micrograms LAP-RGD or LAP-RGE per horn per day delivered in PSA 
vehicle for a total protein concentration of 1 mg/ml; n=5 gilts/treatment group) beginning 
on day 9 of pregnancy.  Pumps delivered either LAP-RGD, LAP-RGE, or PSA into each 
uterine horn at a rate of 10 ul/hour.  
Ovariohysterectomies were performed on day 13 pregnant gilts.  Immediately 
after removal, reproductive tissues were assessed visually to assure placement and 
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patency of catheters and document the conditions of the ovaries and any gross 
abnormalities of the reproductive tract.  Conceptuses were flushed from uterine horns 
with 10 mM Tris.  Uterine horns were opened along the anti-mesometrial border, and 
uterine tissues were preserved by embedding in Tissue-Tek Optimal Cutting Temperature 
Compound (OCT, Miles, Inc, Onenta, NY) and freezing in liquid nitrogen.  Remaining 
uterine tissues were preserved in phosphate buffered 4% paraformaldehyde (PAF) and 
embedded in paraffin. 
 
Immunofluorescence 
 Antibodies used for immunofluorescence staining included: goat anti-LAP (#AB-
246-NA) and chicken anti-TGFB (#AF-101-NA) from R&D Systems (Minneapolis, 
MN);  rabbit anti-ITGAV (#AB1930), ITGB1 (#AB1952), ITGB3 (#AB1932) and 
ITGB5 (#AB1926) integrin subunits from Chemicon (Temecula, CA); and rabbit anti- 
ITGB6 (beta 6, #SC15329) and ITGB8 (beta 8, #SC25714) integrin subunits from Santa 
Cruz (Santa Cruz, CA).  Secondary antibodies used for immunofluorescence staining 
included FITC-conjugated rabbit anti-chicken, Texas Red-conjugated mouse anti-goat 
from Pierce Biotechnology Inc. (Rockford, IL) and FITC-conjugated donkey anti-rabbit 
from Southern Biotech (Birmingham, Alabama).  Anti-LAP detected dimeric and 
monomeric LAP from TGFB isoform 1 in western blotting.  In addition, anti-LAP was 
specific for latent TGFB1 immunostaining (Barcellos-Hoff et al. 1994; Ehrhardt et al. 
1997).  Anti-TGFB recognizes active TGFB1 not associated with LAP (Ehrhardt et al. 
1997).  
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Frozen uterine and conceptus tissues were sectioned (8 µM), mounted on 
Superfrost Plus glass slides (Anapath, Cheyenne, WY), and immunofluorescence co-
localization of LAP and TGFB were performed as described by Ewan et al., (2002) with 
minor modifications.  Frozen sections were fixed with 2% PAF, washed with 0.1 M 
glycine in .02 M phosphate buffered saline (PBS), blocked with 0.5% casein in PBS, and 
incubated overnight at 4oC with TGFB and LAP primary antibodies at concentrations of 
1.25 μg/ml and 15 μg/ml, respectively.  Controls included separate sections incubated 
with TGFB and irrelevant goat IgG; LAP and irrelevant chicken IgG; and with chicken 
IgG and goat IgG.  Sections were incubated with appropriate FITC- or Texas Red- 
conjugated secondary antibodies for 1 h at room temperature at a concentration of 3.75 
μg/ml and 2.5 μg/ml, respectively.  Slides were overlaid with Prolong antifade mounting 
reagent containing the nuclear counterstain DAPI (Invitrogen, Molecular Probes, Eugene, 
OR) and then cover slipped. 
For integrin single labeled immunofluorescence, sections were fixed and washed 
as described above then blocked in 10% normal goat and normal donkey sera.  Sections 
were incubated overnight at 4°C with each integrin subunit ITGAV, ITGB1, ITGB3, 
ITGB5, ITGB6, or ITGB8 primary antibody (5 μg/ml).  Controls included separate 
sections incubated with irrelevant rabbit IgG.  Sections were incubated with FITC- 
conjugated secondary antibodies and cover slipped as described above. 
 
Photomicrography 
Representative immunofluorescence images were collected and analyzed using an 
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Axioplan 2 microscope (Carl Zeiss, Thornwood, NY) interfaced with an Axioplan HR 
digital camera and Axiovision 4.6 software.  Because of Axiovision’s multidimensional 
acquisition with individual fluorophore channels, each fluorophore was captured as 
separate channels, and both single and double labeled sections were visualized.  Images 
were converted to TIFF file format, and Adobe Photoshop CS2 (version 9.0, Adobe 
Systems Inc., San Jose, CA) was used to generate photographic composite images. 
 
In Situ Hybridization 
 Expression of TGFB1, plasminogen activator (PA), matrix metalloproteinases 2 
and 9 (MMP2, 9), and fibronectin (FN) was localized in paraffin-embedded porcine 
uterine tissue by in situ hybridization followed by the Wilcox protocol (Wilcox 1993).  
Paraffin embedded tissues were sectioned (5 µM) and mounted on Superfrost Plus glass 
slides.  Sections were deparaffinized and fixed in 4% PAF.  Hybridizations were 
performed with 5 X 105 cpm [α-35S-UTP] labeled antisense TGFB1, PA, MMP2, MMP9, 
and FN cRNAs at 55o C overnight.  Non specific hybridization was determined using 5 x 
105 cpm [α-35S-UTP] labeled sense estrogen receptor (ER) cRNAs.  Sections were then 
washed and treated with 20 ug/ml RNAse A for 30 min. Sections were washed and 
dehydrated with graded ETOH and allowed to dry for 1 to 4 hr at 37oC.  The signal was 
visualized by exposing the sections to Kodak autoradiographic emulsion NTB-2 at 4oC 
for 6 to 8 weeks.  Sections were counterstained with hematoxylin.          
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Cell Culture 
 Mink lung epithelial cells (MLEC) transfected with an expression construct 
containing a truncated PAI-1 promoter fused to a firefly luciferase reporter gene was 
kindly provided by Dr. D. B. Rifkin.  MLEC were cultured as previously reported (Abe 
et. al. 1994).  Briefly, cells were cultured in DMEM supplemented with 10% fetal bovine 
serum (FBS, Gemini Bio-Products, West Sacramento, CA), 200ug/ml of Geneticin (G-
418 sulfate, Invitrogen Corporation, Carlsbad, CA), L-glutamine (2 mM, Thermo Fisher 
Scientific Inc., Waltham, MA), and penicillin G/ streptomycin sulfate (100 units/ml and 
100 ug/ml, respectively, Thermo Fisher Scientific Inc., Waltham, MA).  Cells were kept 
at 37oC in a 5% CO2 humidified environment.   
 
TGFB Bioassay 
 Total TGFB (active and latent TGFB isoforms 1, 2, and 3 ) in flushes from day 13 
infused pregnant gilts was determined using MLEC transfected with the PAI-1 promoter 
luciferase construct and similar methods as previously described (Abe et. al., 1994).  
MLEC grown to confluence in 25 cm2 culture flasks were passaged using 0.0625% 
trypsin in 0.02% of Moscana/EDTA.  Cells were plated at a concentration of 2.0 X105 
cells per ml on 96-well culture dishes with DMEM supplemented with 10% FBS, L-
glutamine (2 mM), and penicillin G/streptomycin sulfate (100 units/ml and 100 ug/ml, 
respectively), and were allowed to attach for 3 hours at 37oC in a 5% CO2 humidified 
environment.   After removing culture media, a TGFB standard using TGFB1 (R&D 
Systems) and DMEM supplemented with 0.1% BSA, L-glutamine(2 mM), and penicillin 
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G/streptomycin sulfate (100 units/ml and 100 ug/ml, respectively) was serial diluted (500 
pg, 250 pg, 125 pg, 62.5 pg/ml, 31.25 pg/ml, 15.625 pg/ml, 7.8125 pg/ml, 3.90625 pg/ml, 
1.953125 pg/ml, 0.976563 pg/ml) and each dilution was added to three separate wells.  
Flushes from day 13 pregnant gilts were also acid activated with Tris and 1N HCl (pH 
2.2-3.5) for 1 hour on ice to cause cleavage of LAP from TGFB, thereby, activating 
TGFB.  1N NaOH and Tris were then added at a dilution of 1:10 to neutralize the acid.  
Samples were sterile filtered with 0.2um syringe filter (Pall Life Sciences, East Hill, NJ), 
and serial dilutions of samples were made (1:100, 1:200, and 1:400) with DMEM 
supplemented with 1.66% bovine serum albumin (BSA), L-glutamine (2 mM), and 
penicillin G/streptomycin sulfate (100 units/ml and 100 ug/ml, respectively).  Diluted 
samples and standards were then added to wells (3 wells/sample) and incubated for 12-16 
hours at 37oC in a 5% CO2 humidified environment.  Sample and standard media were 
removed from MLEC, briefly washed with 1XPBS, and lysed with Promega Cell Culture 
Lysis Reagent (Promega, Madison, WI) for 20 minutes at 4oC on an orbital shaker.  
Lysates were transferred to opaque 96 well plates and Luciferase Assay Reagent 
(Promega, Madison, WI) was added to each well.  Plates were read on a luminometer 
according to manufacturer’s instructions, Luciferase Assay System (Promega Corp). 
 
Statistical Analysis 
 Data from TGFB bioassay was subjected to ANOVA using general linear models 
procedures of SPSS (SPSS, Inc., Chicago, IL).  ANOVA was used to determine statistical 
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significance between treatment groups (LAP-RGD, LAP-RGE, or PSA) of total TGFB 
amounts within the uterine lumens of infused pregnant gilts. 
 
Results 
TGFB and LAP Colocalization 
 Immunofluorescence analyses were used to co-localize LAP and TGFB in day 13 
uterine tissue of PSA and LAP-RGD infused gilts, with the expectation that these 
analyses would aid our understanding of the fate of infused LAP-RGD and its affect on 
the net balance of active and latent TGFB in the uterus.   
 In PSA infused gilts, LAP (Texas Red) was detected on the surfaces of 
endometrial luminal epithelium (LE), endometrial glandular epithelium (GE), and with 
the endometrial stroma.  TGFB (FITC) was low but detectable on the apical surface of 
LE and within the stroma (data not shown).   
 In LAP-RGD infused gilts, LAP was also detected on apical surfaces of GE and 
within the endometrial stroma.  LAP immunostaining was variable between gilts, but in 
most cases, immunostaining appeared more intense in endometrial tissues compared to 
that in PSA infused gilts.  TGFB immunostaining was low but detectable on the apical 
surfaces of LE and within the stroma (data not shown).   
 The intensity of LAP immunostaining was significantly higher compared to 
TGFB immunostaining in uterine tissue of PSA and LAP-RGD infused gilts; the net 
result was that co-localization of LAP and TGFB (appearing yellow in color) was low 
and, in most cases, undetectable (data not shown).             
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Integrin Immunofluorescence 
 Because active TGFB can alter integrin expression on cell surfaces, and LAP-
RGD can bind to integrins and, potentially, alter their distribution on cell surfaces, 
immunofluorescence analyses were used to localize integrin subunits ITGAV, ITGB1, 
ITGB3, ITGB5, ITGB6, or ITGB8 (FITC) on day 13 uterine tissue of PSA, LAP-RGD, 
and LAP-RGE infused gilts.  In all three treatment groups immunostaining intensities for 
ITGB6 and ITGB8 were low and, in some cases, undetectable (Figure 5.1).  No 
appreciable differences were noted for ITGB6 and ITGB8 in uterine tissue among 
treatment groups.  
   Immunostaining for ITGAV and ITGB5 was detectable and similar in intensity 
in LE and GE.  ITGB3 was also detectable but intensity was low in the LE and GE 
(Figure 5.1).  No appreciable differences were noted for ITGAV, ITGB3, and ITGB5 in 
uterine tissue among treatment groups.  Immunostaining for ITGB1 was detectable in the 
LE and GE and appeared more intense in the LAP-RGD treatment groups as compared to 
that in control PSA and LAP-RGE treatment groups. 
 
TGFB Bioassay 
Flushes from day 13 infused LAP-RGD, LAP-RGE, and PSA pregnant gilts were 
subjected to TGFB bioassay to determine active and total TGFB (active and latent TGFB 
isoforms 1, 2, and 3) using MLEC transfected with the TGFB-responsive PAI-1 promoter 
luciferase construct.  Uterine flushes of all treatment groups (LAP-RGD, LAP-RGE, and
 Figure 5.1. Integrin Subunit Immunofluorescence in Day 13 Porcine Endometrium of PSA, LAPRGD, and LAPRGE 
Treated Gilts.  Immunofluorescence of integrin subunits (ITGAV, ITGB1, ITGB3, ITGB5, ITGB6, ITGB8) in frozen cross-
sections of day 13 pregnant pig endometrium of PSA, LAPRGD, and LAPRGE infused gilts.  Integrin subunit 
immunoreactivity was detected using FITC-conjugated anti-rabbit IgG (green fluorescence).  Compare the antibody staining 
with staining using rabbit and goat IgG (bottom row).  LE, luminal epithelium; GE, glandular epithelium. Width of fields are 
230 µm. 
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Figure 5.1. Continued
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Figure 5.1. Continued
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PSA) were treated with HCl to activate any latent TGFB present in the flushes; total 
amounts detected represent the summation of TGFB that was present in active and latent 
forms at the time of collection. Uterine flushes were also assayed, using varying 
dilutions, without acid-activation, in order to determine amounts of active TGFB present 
at the time of collection.  Amounts of active TGFB were below detectable limits.  The 
means and standard deviations for total TGFB in LAP-RGD, LAP-RGE, and PSA 
treatment groups were 0.77 ± 0.71 ug, 1.65 ± 1.10 ug, 1.26 ± 0.55 ug per horn, 
respectively (Figure 5.2).   Means between LAP-RGD, LAP-RGE, and PSA were 
subjected to ANOVA, and differences were not statistically significant (P > 0.05, Table 
5.1). 
 
In Situ Hybridization 
 TGFB1, PA, MMP2, MMP9, and FN were localized via in situ hybridization in 
day 13 uterine tissue from LAP-RGD, LAP-RGE, and PSA infused gilts.  Expression of 
TGFB1 was low but detectable in LE and GE.  Expression of PA was detected in LE and 
GE, and low levels were detected within the endometrial stroma, particularly within the 
stratum compactum stroma.  Expression of MMP2 was localized in the LE and GE with 
lower levels detected within the stratum compactum stroma.  Expression of MMP9 was 
lower compared to MMP2 but was localized to the LE and GE (data not shown).   
In all transcripts tested in uterine tissues of all treatment groups, FN exhibited the highest 
expression.  Expression of FN was intense and expressed in the outer longitudinal smooth 
muscle layer and, to lesser extent, within the inner circular smooth muscle layer within
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Figure 5.2. Total TGFB (Active and Latent TGFB isoforms 1, 2, and 3) Detected in 
Day 13 Luminal Flushes of LAP-RGD, LAP-RGE and PSA Infused Gilts.  Mean ± 
standard deviations are represented in bar graphs. No differences were detected in total 
TGFB amounts.
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Table 5.1. Total TGFB Activity. Mean ± standard deviations for total TGFB in day 13 
luminal flushes of LAP-RGD, LAP-RGE, and PSA treated gilts. Tests of significance 
were performed using the appropriate error terms according to the expectation of the 
means squares for error, and P < 0.05 was considered statistically significant.  No 
differences were detected in total TFGB amounts. 
 
 
 
 
 
Treatment TGFB Activity (ug) 
PSA  1.2592±0.5455 
LAP-RGD 0.7699±0.3172 
LAP-RGE 1.6457±0.4910 
 TGFB Activity Mean ± SEM (P<0.05) 
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the myometrium.  FN was also abundantly expressed within the walls of blood vessels 
found in the endometrial stroma.  Lower levels of FN were detected within the 
extracellular matrix and GE of the stratum compactum stroma and LE (data not shown).  
 Expression of TGFB1, PA, MMP2, MMP9, and FN did not appear to be different 
between LAP-RGD, LAP-RGE, or PSA treatment groups (data not shown).    
 
Discussion 
 In an attempt to understand the underlying mechanisms resulting in reduction of 
conceptus elongation as seen in LAP-RGD infused gilts, multiple experiments were 
employed.  Results of the present study indicate that there were no detected differences 
between LAP-RGD, LAP-RGE, or PSA infused gilts in:  1) amounts of total TGFB 
within the uterine lumen; 2) integrin expression patterns on endometrial apical surfaces 
and; 3) TGFB regulated genes such as PA, MMP2, MMP1, FN, and TGFB1 in uterine 
tissues.   
 
   TGFB  
 Amounts of active TGFB were below detectable limits.  However, in the presence 
of sera; TGFB activity may be masked.  Indeed, previous studies, have reported that 
factors in sera may cause interference with bioassays (Garrigue-Antar et al. 1995).  
Further alpha 2 macroglobulin which is found in serum is known to modify TGFB 
activity and therefore cause interference.  When latent TGFB was acid activated, active 
TGFB could therefore be detected.  Possibly, the addition of acid may neutralize the 
 
 147
effect of alpha 2 macroglobulin while activating latent TGFB; therefore, intereference is 
minimal when detecting total TGFB.   
 
Integrins 
 Integrins are implicated in mediating conceptus attachment to the uterine LE 
during porcine pregnancy; however, mechanisms mediating conceptus elongation remain 
unknown.  Reorganization and remodeling of the cells of the extra-embryonic tissues and 
hyperplasia have both been implicated in playing a role in conceptus elongation (Geisert 
et al. 1982a, Blomberg et al. 2008).  Pathways involving integrin and TGFB signaling 
have been identified in elongating conceptuses (Blomberg et al. 2008).  Based on results 
of our previous studies, we suggest that reduction in conceptus elongation exhibited in 
LAP-RGD treatment gilts was a result of inappropriately stimulating integrins or 
preventing other integrin-ligand interactions.  Integrins bind to ECM proteins and upon 
stimulation of integrins, they will aggregate to enhance receptor activation and 
intracellular signals.  Aggregation of integrins and differences in apical integrin 
expression were not detected in day 13 porcine endometrium in LAP-RGD, LAP-RGE, 
or PSA treatment groups.  These results do not provide any evidence that integrins 
inappropriately aggregated in response to infused LAP-RGD.  LAP-RGD binding to 
integrins may prevent other ECMs from interacting with the occupied integrins.  
Preventing other integrin-ligand interactions may interrupt intracellular signaling events, 
which may be responsible for up regulation of genes or establishing associations with the 
actin cytoskeleton.  Proper associations with the actin cytoskeleton and up regulation of 
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particular genes may be critical for reorganization and hyperplasia, which may be critical 
in mediating conceptus elongation.  
  
Expression of TGFB Regulated Genes during Porcine Pre-Implantation  
In previous studies, differences were detected in intracellular SMAD signaling 
between LAP-RGD, LAP-RGE, and PSA treatment groups.  TGFB can signal via 
SMADs to regulate gene expression of multiple genes including its own gene, PA, 
MMP2, MMP9, and FN.  No difference was detected between treatment groups for these 
TGFB regulated genes; however, spatial and temporal distributions in these genes were 
noted.   
Expression of TGFB regulated genes PA, MMP2, MMP1, and FN have been 
previously identified in the porcine uterus during pregnancy.  PA converts plasminogen 
to plasmin, and plasmin has been implicated in regulating conceptus invasion in species 
such as mice, which undergo conceptus invasion and decidualization (Salamonsen 1999).  
Plasmin supports conceptus invasion by its actions on degrading the ECM.  In addition, 
plasmin proteolytically activates latent TGFB (Lyons et al. 1990).  PA is produced by 
porcine blastocysts during days 10 to 16 in culture; however, PA could not be detected 
within the uterine lumen after day 12 of pregnancy (Mullins et al. 1980, Fazleabas et al. 
1983).  In situ hybridization results indicate that PA is produced by day 13 endometrial 
epithelium and stratum compactum stroma, suggesting that PA is secreted within the 
uterine lumen.  Plasminogen activator inhibitor (PAI) has been detected in porcine 
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uterine tissues suggesting that PA is inhibited within the porcine uterine lumen as a 
mechanism to prevent ECM degradation and conceptus invasion.   
Other proteases identified during porcine pregnancy include MMP2 and MMP9.  
In previous reports, MMP2 transcripts were detected in blastocysts and uterine tissues 
from days 11 to 16 of pregnancy, while MMP9 transcripts were identified in both embryo 
and uteri between days 15 and 16 and, in some cases, undetectable (Menino et al. 1997, 
Foxcroft et al. 2000).  Results of our studies indicate that MMP9 was indeed present in 
day 13 porcine uterine tissues particularly in the uterine LE, and abundant expression of 
MMP2 was present in the LE and GE.    
Multiple ECM proteins have been identified during porcine pregnancy, including 
FN, which was identified during porcine pregnancy on the apical surfaces of the uterine 
LE and trophectoderm (Rashev et al. 2005).  FN is a ubiquitous homodimeric ECM 
protein that has roles in cellular adhesion, migration, and implantation, and a fetal form – 
oncofetal FN – has been characterized as trophoblastic glue (Jaeger et al. 2001). While 
our results support the finding that FN is found within the porcine uterine LE, FN is most 
abundantly expressed within the myometrium, walls of blood vessels found in the 
endometrial stroma, and to a lesser extent within the extracellular matrix and GE of the 
stratum compactum stroma.    
FN is found within the ECM in many tissues and abundantly found in injured 
tissues because it plays a role in wound healing.  FN associates with fibrillar adhesions 
consisting of integrin α5β1 and tensin, and FN can stretch which accommodates for 
certain cellular activities such as migration and protrusion.  FN is also associated with 
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providing a stable matrix and fibroblast differentiation into myofibroblasts, which is 
critical during these events.  FN is often seen at the edges of wound healing and within 
cardiac valve matrices where migration and cellular contraction is evident (Fayet et al. 
2007).  It is likely that FN found within the porcine uterus, particularly within the 
myometrium and walls of blood vessels, is associated with cell-matrix adhesions 
supporting events of cellular stretch in these structures during pregnancy.           
 In summary, mechanisms supporting conceptus elongation remain unknown, and 
no evidence was obtained to attribute reduction of conceptus elongation as seen in LAP-
RGD treatment groups to LAP-RGD inappropriately stimulating focal adhesion 
formation.  Likewise, we could not associate the observed gross morphological changes 
in expression of TGFB1, PA, MMP2, MMP9, and FN in endometrium, as assessed by in 
situ hybridization.  Further analysis of TGFB- and integrin- regulated factors may 
provide insight in determining mechanisms responsible for inhibiting conceptus 
elongation.  Although the precise nature of the LAP-integrins interactions in the infused 
gilts have not been defined, it is possible that the resultant alterations in downstream 
integrin signaling regulating cellular behaviors such as proliferation and cytoskeletal 
reorganization will result in phenotypic changes such as inhibiting conceptus elongation.     
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CHAPTER VI 
CONCLUSIONS 
 
Introduction 
 There is a high incidence of conceptus and embryonic mortality during the 
porcine peri-implantation period.  The complex networking of autocrine, paracrine, and 
juxtacrine communication at the conceptus-maternal interface is poorly understood; 
however, secretions from both conceptuses and uterus and their interactions are important 
for conceptus attachment and survival.  Among the many growth factors, adhesion 
molecules, steroid hormones, and cytokines found within histotroph or expressed on the 
apical surfaces of the uterine LE and trophectoderm, TGFB and ITGA4, ITGA5, ITGAV, 
ITGB1, ITGB3, and ITGB5 subunits have been detected in both porcine conceptus and 
uterine tissues during the peri-implantation period (Gupta et al. 1998a, Bowen & Hunt 
2000, Burghardt et al. 2002).  The work in this dissertation addressed the roles TGFB and 
integrins have in conceptus-uterine interactions during the porcine peri-implantation 
period.   
 There were two main objectives in this study.  The first objective identified 
interactions between latent TGFB (LAP) and integrins which may result in conceptus 
adhesion and TGFB activation.  Studies were conducted to identify temporal and spatial 
distributions of LAP, TGFB, and integrin subunits (ITGAV, ITGB1, ITGB3, ITGB5, 
ITGB6, and ITGB8), identify LAP as a functional ligand for integrin receptors, and 
provide evidence for TGFB activity in conceptus and uterine tissues during 
 
 152
preimplantation and at the conceptus-maternal interface in pigs.  We used 
immunofluorescence to colocalize LAP and TGFB along with LAP and relevant integrin 
subunits in conceptus and endometrium during the porcine peri-implantation period.  To 
investigate LAP’s capacity to serve as a functional ligand at the conceptus-maternal 
interface, we use cell surface labeling, affinity chromatography, and 
immunoprecipitation.  Finally, to identify evidence of functional TGFB, we used 
immunohistochemistry to detect a TGFB downstream signal, p-SMAD2/3, in both 
conceptus and uterine tissues and at the conceptus-maternal interface.   
 The second objective examined the effects of LAP and TGFB on conceptus 
development, conceptus attachment, and/or placental and fetal development by infusing 
day 9 pregnant gilts with LAP-RGD, LAP-RGE, or PSA control.  Morphology of day 13 
conceptuses was assessed grossly in LAP-RGD, LAP-RGE, and PSA infused gilts.  In 
addition, integrity of implantation sites, along with assessment of placental and fetal 
parameters, were examined in day 24 fetuses of LAP-RGE or PSA infused gilts.  In an 
attempt to determine the mechanism(s) underlying the inhibition of conceptus elongation 
in LAP-RGD infused gilts, we performed various experiments including 
immunofluorescence for LAP, TGFB, and integrin subunits (ITGAV, ITGB1, ITGB3, 
ITGB5, ITGB6, and ITGB8); immunohistochemistry on p-SMAD2/3; and in situ 
hybridization on TGFB regulated genes (PA, MMP2, MMP9, FN, and TGFB).  Our aim 
was to identify differences between LAP-RGD and LAP-RGE treatment groups leading 
to possible mechanisms responsible for mediating conceptus elongation.   
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LAP and TGFB Are Present at the Conceptus-Maternal Interface  
In Chapter III, we identified the spatial and temporal distribution of LAP and 
TGFB in porcine conceptus and endometrium during the peri-implantation period.  
Specificity of the antibodies was critical for this study, and anti-TGFB was specific for 
active TGFB1 (TGFB) not associated with LAP while anti-LAP (LAP) was specific for 
dimeric and monomeric LAP1 and latent TGFB1 in the forms of the SLC and LLC 
(Barcellos-Hoff et al. 1994, Ehrhardt et al. 1997).  Colocalization of LAP and TGFB 
during the peri-implantation period in pigs (days 10, 12, 16, 20, and 24 of pregnancy) 
provided a means by which to visualize temporal and spatial activation of TGFB, 
sequestration of latent TGFB, and distribution of LAP that may serve as an integrin 
ligand.   
 Results of this study demonstrated LAP and TGFB at the conceptus-maternal 
interface.  The detection of LAP in conceptus and endometrial tissues, along with earlier 
data (Gupta et al. 1996, Gupta et al. 1998a), support the finding that both the conceptus 
and uterus are potential sources of secreted TGFB.  Further, abundant LAP 
immunostaining detected on the apical surfaces of GE on days 16 and 20 of pregnancy 
suggests that the GE secrete latent TGFB as a component of histotroph.  Results of this 
study also provide evidence that activation of TGFB occurs at the apical surfaces of 
uterine LE, trophectoderm, and at the conceptus-maternal interface, potentially resulting 
in TGFB and TGFBR functional interactions.  Activation of TGFB at these apical 
surfaces may be occurring, in part, by proteases and integrins.  
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 Large aggregates of LAP at the conceptus-maternal interface by day 24 of 
pregnancy provide evidence that LAP is a potential adhesion molecule promoting 
attachment of the conceptus to the uterine LE via binding to integrin receptors.  In 
addition, aggregation of LAP suggests sequestration of latent TGFB as a reservoir for 
later in pregnancy; however, detection of low levels of immunostaining for TGFB during 
the late stages of porcine implantation (day 24 of pregnancy) also indicate that there is 
ongoing activation of TGFB, and suggests a need for active TGFB during this time.   
 
LAP and Integrin Interactions Potentially Support Conceptus Attachment 
Dual label immunofluorescence of LAP with each integrin subunit (ITGAV, 
ITGB1, ITGB3, ITGB5, ITGB6, and ITGB8), described in Chapter III, was essential in 
placing LAP in close proximity to integrin receptors to support the hypothesis that LAP is 
a potential integrin ligand during the porcine peri-implantation period.  Immunostaining 
for ITGAV, ITGB1, ITGB3, and ITGB5 were detected in endometrial and conceptus 
tissues from days 10 through 24 of pregnancy, became more apical in distribution as 
pregnancy progressed, and aggregated at the conceptus-maternal interface.  ITGB1 and 
ITGB5 formed large distinct aggregates, particularly in the LE, at the conceptus-maternal 
interface by day 20 of pregnancy and were maintained through day 24.  Intermittent 
aggregates for ITGB3 were detected at the conceptus-maternal interface by day 24.  
Aggregates for ITGB1, ITGB3, and ITGB5 were absent at the apical surface of LE at 
non-attachment sites, strongly suggesting that aggregates form in response to ligand 
binding that serve to attach trophectoderm to LE for stable attachment.  Further, LAP did 
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not precisely co-localize with ITGB1, ITGB3, and ITGB5 but appeared to be distributed 
in the matrix that resides between the trophectoderm and LE, which perfectly places this 
protein to bind ITGB1, ITGB3, and ITGB5 integrins and serve as an adhesion molecule.  
Indeed, ITGAV, ITGB1, ITGB3, ITGB5, ITGB6, and ITGB8 expressed on the apical 
surfaces of a porcine trophectoderm cell line bound to LAP immobilized on an affinity 
column, further supporting the hypothesis that LAP binds to integrins at the porcine 
conceptus-maternal interface to support conceptus attachment.   
Results from this study were the first to report ITGB1 and ITGB5 aggregation at 
the conceptus-maternal interface in any species; however, aggregation of integrins and 
focal adhesion assembly at the conceptus-maternal interface in sheep and pigs was 
recently reported (Burghardt et al. 2009, Erikson et al. 2009).  Upon binding of ECM 
proteins, integrins aggregate to enhance signal transduction and form cytoplasmic focal 
adhesions that associate with the actin cytoskeleton (Wozniak et al. 2004), and our 
detection of  ITGB1 and ITGB5 aggregates provides evidence of induced focal adhesions 
at the conceptus-maternal interface in pigs.  Formation of focal adhesions stabilizes cell 
attachments to the ECM by connecting ECM proteins to the actin cytoskeleton via actin 
filaments (Bershadsky et al. 2006a).  Focal adhesions also serve as signaling centers from 
which numerous intracellular pathways can regulate cell growth, proliferation, survival, 
gene expression, development, tissue repair, migration and invasion.  Our results imply 
that integrins bind to ECM proteins such as LAP to induce integrin aggregation and focal 
adhesion assembly that stabilizes conceptus attachment (Figure 6.1) and potentially 
induces intracellular pathways to regulate cellular behavior such as cell growth,
 Figure 6.1. Proposed Model for Actions of TGFB and Integrins in Conceptus and Uterine Tissues at the Conceptus-
Maternal Interface.  Integrin heterodimers on porcine trophectoderm (Tr) and uterine LE bind to LAP via its RGD sequence, 
induce integrin aggregation, and induce focal adhesion assembly to support conceptus attachment to the LE during porcine 
implantation.
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proliferation, and migration which may be critical to support conceptus development and 
attachment.       
 It is noteworthy that aggregates of ITGB3 were not detected until the later stage 
of porcine implantation, while aggregates of ITGB1 and ITGB5 appeared by mid 
implantation.  Changes in the integrin repertoire on LE, have been detected during 
implantation in many species and, particularly with αvβ3, are associated with stabilizing 
stronger conceptus adhesions (Johnson et al. 2001, Burghardt et al. 2002, Lessey 2002, 
Armant 2005).  During porcine implantation, ITGB1 and ITGB5, presumably as the 
heterodimers αvβ1 and αvβ5, may play important roles for stabilizing initial attachments 
of the conceptus to the LE.  As implantation progresses, up regulation of ITGB3, 
presumably as αvβ3, along with αvβ1 and αvβ5, may be necessary to support stronger 
placental attachments of the growing embryo.     
 
TGFB Activation at the Porcine Conceptus-Maternal Interface 
 Abundant immunostaining for active TGFB was detected along the apical 
surfaces of filamentous conceptuses by day 12 of pregnancy and at the conceptus-
maternal interface beginning by day 16 of pregnancy, suggesting that activation occurs 
along these surfaces.  Activation of TGFB can occur via proteases and integrins in the 
presence and absence of proteases (Jenkins 2008, Wipff & Hinz 2008).   
 LAP and ITGAV, ITGB1, ITGB3, ITGB5, and low levels of ITGB6 and ITGB8 
were detected along the uterine LE.  Notably, αvβ3, αvβ5, αvβ6, and possibly αvβ1, have 
been determined to activate latent TGFB by mechanical forces such as cellular 
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contraction and external stretching (Jenkins et al. 2006, Wipff et al. 2007).  During 
porcine implantation, the conceptus migrates along the uterine LE, and the migrating 
conceptus may be a source of external force applied to the LAP-integrin adhesion 
complex.  Results from Chapter III suggest that the apically bound LAP-integrin 
adhesion complex, in addition to supporting conceptus attachments, can also activate 
TGFB by inducing conformational changes in the latent complex.  The conformational 
change generated by conceptus movement along the uterine LE may cause external 
stretch on the LLC and therefore liberate TGFB (Figure 6.2).   
 Intracellular forces such as cellular contraction generated by cross-bridging of 
ACTA2 and myosin may also play a role in activating TGFB during porcine 
implantation.  The subepithelial stroma of pigs undergoes remodeling during pregnancy 
that is associated with the up regulation of α-smooth muscle actin (ACTA2) within 
myofibroblast-like stromal cells (Johnson et al. 2003).  It is possible that in the porcine 
uterus, contraction of the actin filaments associated with integrins generates a force on 
the LAP- integrin complex, causing a conformational change in the LLC, and liberating 
TGFB from its latent complex. As reported here, latent TGFB localized within the ECM 
of the stroma during porcine implantation may be subjected to activation by integrins 
transmitting intracellular mechanical forces.   
 Proteases involved in TGFB activation include, but not limited to, plasmin and 
MMP’s, which function by proteolytic cleavage of LAP (Jenkins 2008).  Independent of 
traction forces, integrins also aid in proteolytic cleavage of LAP from TGFB during 
TGFB activation.  For example, αvβ8 forms a cell surface complex with the 
 Figure 6.2. Proposed Model for Actions of TGFB and Integrins in Conceptus and Uterine Tissues at the Conceptus-
Maternal Interface.  A, Integrin heterodimers on porcine trophectoderm (Tr) and uterine LE bind to LAP via its RGD 
sequence serving to support conceptus attachment to the LE during porcine implantation.  B, LAP bound to integrins αvβ3, 
αvβ5, αvβ6, and possibly αvβ1 may serve to activate TGFB.  C, TGFB signals via TGFBRs to activate intracellular signaling 
pathways, most commonly involving SMADs to control transcription of many genes.   
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transmembrane matrix metalloproteinase MMP14 (MT1-MMP).  Integrin αvβ8 binds 
LAP that sequesters latent TGFB at the luminal surface and presents the latent TGFB to 
MT1-MMP where it cleaves LAP and releases active TGFB (Mu et al. 2002).  MT1-
MMP has been identified in the synepitheliochorial placenta in sheep and goats (Uekita et 
al. 2004), but to our knowledge MTI-MMP has not yet been investigated in pig 
implantation.  Integrin αvβ3 is also hypothesized to participate in proteolytic activation of 
TGFB since αvβ3 may serve as a docking station for MMP2 and MMP9 along with latent 
TGFB.  Similar to MT1-MMP, MMP2 and MMP9 activates TGFB by cleaving LAP and 
releasing TGFB (Wipff & Hinz 2008).  MMP2 was detected in porcine blastocysts and 
peri-implantation uterine tissues (Menino et al. 1997, Foxcroft et al. 2000).  Not 
surprisingly, tissue inhibitors of matrix metalloproteinases (TIMP1, 2, and 3) have been 
localized in the trophectoderm and endometrial stroma, and TIMP2 was detected in 
uterine flushes during porcine pre-implantation and early implantation (Menino et al. 
1997, Kayser et al. 2006).  While inhibiting the proteolytic actions of MMPs via TIMPs 
may be important in inhibiting conceptus invasion during porcine epitheliochorial 
implantation, MMP2 may temporally activate TGFB at the apical surfaces of LE and GE, 
where expression of TIMPS1, 2, and 3 were not detected (Menino et al. 1997).   
 We propose therefore that ITGAV-containing heterodimers participate in TGFB 
activation during porcine implantation via mechanisms including, but not limited to, 
traction forces.  Forces generated by the conceptus may be a mechanism for activating 
TGFB at sites of conceptus contact, and forces generated from within the cell may be a 
mechanism for activating TGFB within the endometrial stroma.  In addition, proteases 
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such as MMP-2 alone or in combination with integrins may also aid in activating TGFB 
at non-attachment sites or within glandular lumens.  Active TGFB can therefore, bind and 
activate TGFBRs at both conceptus attachment and non-attachment sites (Figure 6.2). 
  
LAP-RGD Reduces Conceptus Elongation  
 Mechanisms supporting conceptus elongation are largely unknown, but altering 
the uterine environment during the peri-implantation period may alter conceptus 
development and survival (Wilson et al. 2001).  In attempt to uncover mechanisms 
supporting conceptus elongation and attachment, experimental intrauterine infusions with 
implantable osmotic pumps were utilized to deliver LAP-RGD, LAP-RGE, or PSA 
directly into the uterine horns of early pregnant gilts, described in Chapter IV.  Such 
experimental infusions have not been used to investigate conceptus development and 
attachment during the peri-implantation period in pregnant swine.  We successfully 
established a delivery system with the use of mini osmotic pumps that remained 
contained within the abdominal cavity, enabled controlled delivery of substances to the 
uterine lumen of pregnant gilts, and maintained pregnancy throughout the implantation 
period.  This system allowed for exogenous LAP, at physiological concentrations, to be 
directly infused into the uterus of pregnant gilts with interiorized catheters and minimal 
post surgery manipulation or restraints.  Inappropriate LAP-RGD infused into the uterine 
lumen of pregnant gilts beginning at day 9 of pregnancy was expected to disrupt the 
balance of active TGFB and alter normal integrin signaling, whereas LAP-RGE infusions 
were expected to similarly affect the TGFB activity, but not alter integrin interactions.    
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 Day 13 conceptuses collected from pregnant gilts infused with LAP-RGD 
exhibited a dramatic reduction in elongation; whereas, the overall morphology of 
conceptuses in both LAP-RGE and PSA treatment group was grossly normal.  In attempt 
to understand the underlying mechanisms resulting in reduction of conceptus elongation 
as seen in LAP-RGD infused gilts, multiple experiments including immunofluorescence, 
immunohistochemistry, and in situ hybridization were employed.  Detection of p-
SMAD2/3 in day 13 conceptus and endometrial tissues, described in Chapter IV, 
provides evidence that activity of TGFB was not inhibited in LAP-RGD infused gilts.  
Further, results from Chapter V provide no evidence of differences in 1) amounts of total 
TGFB within the uterine lumen; 2) integrin expression patterns on endometrial apical 
surfaces and; 3) expression of TGFB regulated genes such as PA, MMP2, MMP1, FN, 
and TGFB1 in uterine tissues that could be linked to the inhibition of conceptus 
elongation.  Further analysis of TGFB- and integrin- regulated factors via microarray 
analyses and detection of phosphorylated intracellular signaling proteins may provide 
insight in determining mechanisms responsible for inhibiting conceptus elongation. 
 Based on the findings that LAP-RGD treatment groups exhibited a reduction in 
conceptus elongation, whereas, LAP-RGE did not affect elongation, we hypothesize that 
the RGD sequence in LAP-RGD treatment groups mediated the inhibition of conceptus 
elongation, and the observed phenotype.  It is possible that LAP-RGD bound to integrins 
prevented other ligands such as FN, SPP1, or VN from binding to integrins, thus resulting 
in inappropriate integrin intracellular signaling or prevention of signaling.  In addition, 
the presence of spherical conceptuses on day 13 of porcine pregnancy, a phenotype 
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normally detected prior to day 11, provides evidence that altering or interfering with 
downstream integrin and/or TGFB signaling within a critical window encompassing day 
10 of pregnancy inhibits critical, initiating signals mediating conceptus elongation.  
       
LAP-RGE Increases Placental Size  
 Because conceptus elongation in LAP-RGD infused gilts was severely inhibited 
and, in many cases, conceptuses appeared fragmented or as trophoblastic sheets, it is 
unlikely that the pregnancy would have continued to day 24 of pregnancy.  In many gilts 
that received LAP-RGD from days 9 to 13, degenerating cells and necrotic tissue found 
in luminal flushes suggested that pregnancy resorption was occurring.  In study 1 in 
Chapter IV, LAP-RGE infused gilts exhibited normal conceptus elongation; therefore, a 
second study was designed to evaluate effects of LAP-RGE or PSA infusions on 
placental and fetal parameters such as fetal weight, number, and crown-rump length and 
allantoic length and allantoic fluid volume.  Infusions began on day 9 of pregnancy, 
continued for 6.5 days, and ovariohysterectomies were performed on day 24 of 
pregnancy.  Infusing LAP-RGE resulted in larger fetal weight (P < 0.05), allantoic length 
(P < 0.05), and allantoic fluid volume (P < 0.01) compared to the PSA treatment group.   
  Results from Chapter IV provide evidence that infusing LAP-RGE results in a 
decrease in SMAD2/3 signaling in the uterine LE by day 13 of pregnancy, suggesting 
that the phenotype seen at day 24 of pregnancy may be a result of altering TGFB induced 
SMAD2/3 signaling in epithelial cells during the critical time of conceptus elongation.  
Further, the apparent decrease in p-SMAD2/3 in epithelial cells, potentially caused by 
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reduced TGFB activity, may alter cellular growth arrest, proliferation, and migration in 
epithelial cells, which may ultimately affect porcine placental and fetal parameters 
including fetal weights, allantoic length, and allantoic fluid volume.     
 
 Functional TGFB at the Conceptus-Maternal Interface and Potential TGFBR and 
Integrin Cross-Talk   
 TGFB signals via SMAD and less characterized SMAD-independent pathways 
and functions to elicit different cellular behaviors such as growth, proliferation, 
apoptosis, and differentiation.  In multiple species, TGFB has been indirectly linked to 
regulating trophoblast attachment and invasion by enhancing production of ECM proteins 
such as oFN (Feinberg et al. 1994), inducing expression of integrins (Zambruno et al. 
1995, Kagami et al. 1996, Lai et al. 2000, Pechkovsky et al. 2008), and reducing 
production of proteases such as MMPs and plasmin (Graham & Lala 1991, Graham 1997, 
Kallapur et al. 1999, Karmakar & Das 2002).  TGFBR downstream p-SMAD2/3 
signaling identified in porcine conceptus and uterine tissues, described in Chapter III, 
may function to regulate transcription of genes encoding for adhesion molecules, such as 
oFN and SPP1; protease inhibitors, such as PAI and TIMPs; and integrins during the 
peri-implantation period in pigs.  Therefore, TGFB acting via intracellular SMAD 
signaling may be functioning in regulating processes such as adhesion and invasion in 
porcine pregnancy. 
 There is evidence to support that integrins cluster with TGFBRs, and cross-talk 
between growth factor receptors and integrins have been implicated in growth, 
 
 167
proliferation, migration, and angiogenesis.  At the porcine conceptus-maternal interface, 
integrins clustering with TGFBRs may not only be important during TGFB activation and 
subsequent TGFB and TGFBR interactions, but may be critical for intracellular signaling 
cross-talk.  Cooperation between integrins and growth factors can activate signaling 
cascades such as Ras-ERK and MAPK c-Jun NH2-terminal kinase (JNK) that can 
regulate cell cycle progression and growth (Eliceiri 2001).  TGFBR and integrin 
cytoplasmic domains, such as ITGB1 and ITGB3, may be linked via ILK, PINCH-1, and 
NCK2 resulting in synergy between TGFB and integrin intracellular signaling regulating 
growth, proliferation, and migration in epithelial cells at the porcine conceptus-maternal 
interface.   
 Integrin-mediated cell adhesion to the correct ECM appears to be important for 
optimal growth factor stimulation, and it appears that integrins preferentially associate 
with specific growth factor receptors.  For example, in the presence of certain integrin 
ligands, αvβ5 requires growth factor stimulation for integrin-mediated cell migration, 
while αvβ3 exhibits growth factor-independent migration.  Indeed, cell migration occurs 
in the presence of EGF or insulin when αvβ5-vitronectin interactions support cell 
attachments.  ITGB3 and ITGB5 have been identified at the porcine conceptus-maternal 
interface, and while αvβ3 and αvβ5 may support adhesion of the conceptus to the uterine 
LE, they may also mediate other cellular events such as migration in the presence of 
particular adhesion molecules and growth factors, potentially including LAP and TGFB, 
respectively.  Further, at the porcine conceptus-maternal interface TGFB activity via 
SMAD-dependent and/or SMAD-independent pathways may regulate these events by 
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inducing expression of  ITGB3 and ITGB5 and subsequent apical expression of αvβ3 and 
αvβ5 and regulating components of the ECM, particularly FN and VN.  Mechanisms 
controlling TGFB and integrin activity, as described here, may aid in the underlying 
causes of the phenotypic changes detected in conceptus, placental, and fetal development, 
as described in Chapter IV.         
 Results in Chapter III provide evidence of focal adhesion assembly to support 
conceptus attachment.  TGFB may aid in initiating focal adhesion assembly during 
porcine implantation by activating FAK and αvβ3 via SMADs and MAPK, respectively.  
TGFB may also regulate size of focal adhesions by increasing intracellular stress by 
mechanisms such as increasing ECM composition and activating ACTA2, Rho, and Rho 
kinase that increase myosin contraction.  In addition, TGFB may regulate the 
differentiation and remodeling of the subepithelial stroma in pigs during pregnancy by up 
regulating ACTA2 that is associated with myofibroblast-like stromal cells. 
  
Final Conclusions 
 The series of studies conducted have revealed that interactions among active 
TGFB, latent TGFB (LAP), and integrins are complex, and appear to play important 
roles during the peri-implantation period in pigs.  Prior to this project, TGFB was 
detected during porcine pregnancy; however, evidence for functional TGFB and the 
potential actions of TGFB during the porcine peri-implantation period were largely 
unknown.  Overall, this project provided evidence for 1) TGFB activity in porcine 
conceptus and uterine tissues; 2) receptor-ligand interactions of LAP and integrins; 3) 
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integrin aggregation and potential focal adhesion formation at the conceptus-maternal 
interface; and 4) TGFB- and/or integrin-associated mechanisms during pre-implantation 
regulate porcine conceptus elongation and placental and fetal size.  Collectively, results 
of this project suggest that TGFB and integrins are extensively involved in autocrine, 
paracrine, and juxtacrine communication at the porcine conceptus-maternal interface, 
particularly that regulating conceptus development, adhesion, and placental and fetal 
development.  Future studies are warranted and should include those focused on 
determining the exact mechanisms of TGFB and integrin intracellular signaling that 
regulate events of implantation and placentation.  Better understanding of these 
processes provides insight into improving the reproductive success in many mammals 
including humans. 
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